LYSP100	B-protein
-associated	O
nuclear	O
domains	O
(	O
LANDs	O
)	O
:	O
description	O
of	O
a	O
new	O
class	O
of	O
subnuclear	O
structures	O
and	O
their	O
relationship	O
to	O
PML	O
nuclear	O
bodies	O
.	O

The	O
PML	B-DNA
gene	I-DNA
is	O
fused	O
to	O
the	O
retinoic	B-DNA
acid	I-DNA
receptor	I-DNA
alpha	I-DNA
(	I-DNA
RAR	I-DNA
alpha	I-DNA
)	I-DNA
gene	I-DNA
in	O
t	O
(	O
15	O
;	O
17	O
)	O
acute	O
promyelocytic	O
leukemia	O
(	O
APL	O
)	O
,	O
creating	O
a	O
PML-RAR	B-protein
alpha	I-protein
fusion	I-protein
oncoprotein	I-protein
.	O

The	O
PML	B-protein
gene	I-protein
product	I-protein
has	O
been	O
localized	O
to	O
subnuclear	B-cell_line
dot-like	I-cell_line
structures	I-cell_line
variously	O
termed	O
PODs	O
,	O
ND10s	O
,	O
Kr	O
bodies	O
,	O
or	O
PML	O
nuclear	O
bodies	O
(	O
PML	O
NBs	O
)	O
.	O

The	O
present	O
study	O
describes	O
the	O
cloning	O
of	O
a	O
lymphoid-restricted	B-DNA
gene	I-DNA
,	O
LYSP100	B-DNA
,	O
that	O
is	O
homologous	O
to	O
another	O
protein	O
that	O
localizes	O
to	O
PML	O
NBs	O
,	O
SP100	B-protein
.	O

In	O
addition	O
to	O
SP100	B-DNA
homology	I-DNA
regions	I-DNA
,	O
one	O
LYSP100	B-DNA
cDNA	I-DNA
isoform	I-DNA
contains	O
a	O
bromodomain	B-protein
and	O
a	O
PHD/TTC	B-protein
domain	I-protein
,	O
which	O
are	O
present	O
in	O
a	O
variety	O
of	O
transcriptional	B-protein
regulatory	I-protein
proteins	I-protein
.	O

By	O
immunofluorescence	O
,	O
LYSP100	B-DNA
was	O
localized	O
to	O
nuclear	O
dots	O
that	O
were	O
surprisingly	O
largely	O
nonoverlapping	O
with	O
PML	O
NBs	O
.	O

However	O
,	O
a	O
minority	O
of	O
LYSP100	B-DNA
nuclear	O
dots	O
exactly	O
colocalized	O
with	O
PML	B-cell_type
and	O
SP100	B-protein
.	O

We	O
term	O
the	O
LYSP100	B-DNA
structures	O
``	O
LANDs	O
,	O
''	O
for	O
LYSP100	B-DNA
-associated	O
nuclear	O
domains	O
.	O

Although	O
LYSP100	B-DNA
is	O
expressed	O
only	O
in	O
lymphoid	B-cell_type
cells	I-cell_type
,	O
LANDs	O
could	O
be	O
visualized	O
in	O
HeLa	B-cell_line
cells	I-cell_line
by	O
transfection	O
of	O
a	O
LYSP100	B-DNA
cDNA	I-DNA
.	O

Immunoelectron	O
microscopy	O
revealed	O
LANDs	O
to	O
be	O
globular	O
,	O
electron-dense	O
structures	O
morphologically	O
distinct	O
from	O
the	O
annular	O
structures	O
characteristic	O
of	O
PML	O
NBs	O
.	O

LANDs	O
were	O
most	O
often	O
found	O
in	O
the	O
nucleoplasm	O
,	O
but	O
were	O
also	O
found	O
at	O
the	O
nuclear	O
membrane	O
and	O
in	O
the	O
cytoplasm	O
,	O
suggesting	O
that	O
these	O
structures	O
may	O
traffic	O
between	O
the	O
cytoplasm	O
and	O
the	O
nucleus	O
.	O

By	O
double-immunogold	O
labeling	O
of	O
PML	B-cell_type
and	O
LYSP100	B-DNA
,	O
some	O
LANDs	O
were	O
shown	O
to	O
contain	O
both	O
PML	B-cell_type
and	O
LYSP100	B-DNA
.	O

Thus	O
,	O
PML	B-cell_type
is	O
localized	O
to	O
a	O
second	O
subnuclear	O
domain	O
that	O
is	O
morphologically	O
and	O
biochemically	O
distinct	O
from	O
PML	B-cell_type
NBs	O
.	O

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

LYSP100-Associated	NULL
Nuclear	NULL
Domains	NULL
(	NULL
LANDs	NULL
)	NULL
:	NULL
Description	NULL
of	NULL
a	NULL
New	NULL
Class	NULL
of	NULL
Subnuclear	NULL
Structures	NULL
and	NULL
Their	NULL
Relationship	NULL
to	NULL
PML	NULL
Nuclear	NULL
Bodies	NULL
By	NULL
Alexander	NULL
L.	NULL
Dent	NULL
,	NULL
Jonathan	NULL
Yewdell	NULL
,	NULL
Francine	NULL
Puvion-Dutilleul	NULL
,	NULL
Marcel	NULL
H.M.	NULL
Koken	NULL
,	NULL
Hugues	NULL
de	NULL
The	NULL
,	NULL
and	NULL
Louis	NULL
M.	NULL
Staudt	NULL
The	NULL
PML	NULL
gene	NULL
is	NULL
fused	NULL
to	NULL
the	NULL
retinoic	NULL
acid	NULL
receptor	NULL
a	NULL
(	NULL
RARa	NULL
)	NULL
gene	NULL
in	NULL
t	NULL
(	NULL
15	NULL
;	NULL
17	NULL
)	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
(	NULL
APL	NULL
)	NULL
,	NULL
creating	NULL
a	NULL
PML-RARa	NULL
«	NULL
fusion	NULL
oncoprotein	NULL
.	NULL

The	NULL
PML	NULL
gene	NULL
product	NULL
has	NULL
been	NULL
localized	NULL
to	NULL
subnuclear	NULL
dot-like	NULL
structures	NULL
variously	NULL
termed	NULL
PODs	NULL
,	NULL
ND10s	NULL
,	NULL
Kr	NULL
bodies	NULL
,	NULL
or	NULL
PML	NULL
nuclear	NULL
bodies	NULL
{	NULL
PML	NULL
NBs	NULL
)	NULL
.	NULL

The	NULL
present	NULL
study	NULL
describes	NULL
the	NULL
cloning	NULL
of	NULL
a	NULL
lymphoid-restricted	NULL
gene	NULL
,	NULL
LYSP100	NULL
,	NULL
that	NULL
is	NULL
homologous	NULL
to	NULL
another	NULL
protein	NULL
that	NULL
localizes	NULL
to	NULL
PML	NULL
NBs	NULL
,	NULL
SP100	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
SP100	NULL
homology	NULL
regions	NULL
,	NULL
one	NULL
LYSP100	NULL
cDNA	NULL
isoform	NULL
contains	NULL
a	NULL
bromodomain	NULL
and	NULL
a	NULL
PHD/TTC	NULL
domain	NULL
,	NULL
which	NULL
are	NULL
present	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
transcriptional	NULL
regulatory	NULL
proteins	NULL
.	NULL

By	NULL
immunofluorescence	NULL
,	NULL
LYSP100	NULL
was	NULL
localized	NULL
to	NULL
nuclear	NULL
dots	NULL
that	NULL
were	NULL
surprisingly	NULL
largely	NULL
nonoverlapping	NULL
with	NULL
PML	NULL
NBs	NULL
.	NULL

However	NULL
,	NULL
a	NULL
minority	NULL
of	NULL
LYSP100	NULL
nuclear	NULL
dots	NULL
exactly	NULL
colocalized	NULL
with	NULL
PML	NULL
and	NULL
SP100	NULL
.	NULL

We	NULL
term	NULL
the	NULL
LYSP100	NULL
HE	NULL
INTERPHASE	NULL
CELL	NULL
nucleus	NULL
is	NULL
compartmentalized	NULL
into	NULL
different	NULL
structural	NULL
domains	NULL
that	NULL
are	NULL
important	NULL
for	NULL
nuclear	NULL
function	NULL
(	NULL
see	NULL
Spector	NULL
'	NULL
for	NULL
review	NULL
)	NULL
.	NULL

The	NULL
nucleolus	NULL
,	NULL
the	NULL
most	NULL
prominent	NULL
subnuclear	NULL
domain	NULL
,	NULL
assembles	NULL
ribosomes	NULL
.	NULL

Other	NULL
classes	NULL
of	NULL
subnuclear	NULL
domains	NULL
,	NULL
such	NULL
as	NULL
interchromatin	NULL
granules	NULL
,	NULL
interchromatin	NULL
fibrils	NULL
,	NULL
coiled	NULL
bodies	NULL
,	NULL
and	NULL
nuclear	NULL
bodies	NULL
(	NULL
NBs	NULL
)	NULL
,	NULL
were	NULL
initially	NULL
defined	NULL
as	NULL
morphologically	NULL
distinct	NULL
structures	NULL
by	NULL
electron	NULL
microscopy	NULL
(	NULL
EM	NULL
)	NULL
.	NULL

Subsequently	NULL
,	NULL
antibody	NULL
probes	NULL
have	NULL
been	NULL
used	NULL
to	NULL
distinguish	NULL
subnuclear	NULL
domains	NULL
biochemically	NULL
.	NULL

For	NULL
example	NULL
,	NULL
a	NULL
variety	NULL
of	NULL
splicing	NULL
factors	NULL
have	NULL
been	NULL
localized	NULL
to	NULL
both	NULL
interchromatin	NULL
granules	NULL
and	NULL
coiled	NULL
bodies	NULL
.	NULL

The	NULL
processes	NULL
of	NULL
transcription	NULL
,	NULL
splicing	NULL
,	NULL
and	NULL
DNA	NULL
replication	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
take	NULL
place	NULL
in	NULL
localized	NULL
regions	NULL
of	NULL
the	NULL
nucleus	NULL
,	NULL
although	NULL
the	NULL
relation	NULL
of	NULL
these	NULL
events	NULL
to	NULL
the	NULL
morphologically	NULL
defined	NULL
subnuclear	NULL
structures	NULL
remains	NULL
to	NULL
be	NULL
fully	NULL
elucidated	NULL
.	NULL

An	NULL
ultrastructurally	NULL
distinct	NULL
subnuclear	NULL
structure	NULL
,	NULL
variously	NULL
termed	NULL
the	NULL
PML	NULL
NB	NULL
,	NULL
``	NULL
POD	NULL
,	NULL
*	NULL
NDI1O0	NULL
,	NULL
°	NULL
or	NULL
Kr	NULL
body	NULL
,	NULL
°	NULL
has	NULL
recently	NULL
been	NULL
studied	NULL
intensively	NULL
due	NULL
to	NULL
the	NULL
observation	NULL
that	NULL
the	NULL
PML	NULL
protein	NULL
localizes	NULL
to	NULL
this	NULL
domain	NULL
.	NULL
``	NULL

Interest	NULL
in	NULL
the	NULL
PML	NULL
gene	NULL
derives	NULL
from	NULL
its	NULL
involvement	NULL
in	NULL
the	NULL
characteristic	NULL
t	NULL
(	NULL
15	NULL
;	NULL
17	NULL
)	NULL
translocation	NULL
of	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
(	NULL
APL	NULL
)	NULL
.	NULL

*	NULL
``	NULL
By	NULL
immunofluorescence	NULL
,	NULL
the	NULL
wild-type	NULL
PML	NULL
protein	NULL
localizes	NULL
to	NULL
five	NULL
to	NULL
15	NULL
dot-like	NULL
or	NULL
ring-like	NULL
domains	NULL
in	NULL
the	NULL
nucleus	NULL
.	NULL

**	NULL
``	NULL
``	NULL
``	NULL
``	NULL
``	NULL
``	NULL
``	NULL
Using	NULL
immuno-EM	NULL
,	NULL
PML	NULL
was	NULL
detected	NULL
in	NULL
annular	NULL
or	NULL
dot-like	NULL
,	NULL
electron-dense	NULL
structures	NULL
in	NULL
the	NULL
nucleoplasm	NULL
,	NULL
0.3	NULL
to	NULL
1	NULL
wm	NULL
in	NULL
diameter	NULL
.	NULL

*	NULL
``	NULL
'	NULL
``	NULL
PML	NULL
preferentially	NULL
localized	NULL
over	NULL
the	NULL
electron-dense	NULL
outer	NULL
ring	NULL
of	NULL
these	NULL
structures	NULL
.	NULL

This	NULL
PML-containing	NULL
structure	NULL
is	NULL
morphologically	NULL
similar	NULL
to	NULL
a	NULL
subclass	NULL
of	NULL
NBs	NULL
previously	NULL
defined	NULL
by	NULL
EM	NULL
(	NULL
re-viewed	NULL
in	NULL
Brasch	NULL
and	NULL
Ochs	NULL
``	NULL
)	NULL
,	NULL
and	NULL
thus	NULL
we	NULL
will	NULL
term	NULL
this	NULL
structure	NULL
a	NULL
PML	NULL
NB	NULL
in	NULL
the	NULL
present	NULL
study	NULL
.	NULL

Although	NULL
the	NULL
normal	NULL
function	NULL
of	NULL
PML	NULL
NBs	NULL
has	NULL
remained	NULL
elusive	NULL
,	NULL
a	NULL
clue	NULL
to	NULL
their	NULL
importance	NULL
comes	NULL
from	NULL
the	NULL
observation	NULL
that	NULL
DNA	NULL
viruses	NULL
encode	NULL
proteins	NULL
that	NULL
localize	NULL
to	NULL
PML	NULL
NBs	NULL
transiently	NULL
and	NULL
subsequently	NULL
disrupt	NULL
the	NULL
structures	NULL
.	NULL

``	NULL
``	NULL
``	NULL
*	NULL
The	NULL
t	NULL
(	NULL
15	NULL
;	NULL
17	NULL
)	NULL
translocation	NULL
of	NULL
APL	NULL
results	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
fusion	NULL
oncoprotein	NULL
in	NULL
which	NULL
PML	NULL
is	NULL
fused	NULL
to	NULL
the	NULL
retinoic	NULL
acid	NULL
receptor	NULL
a	NULL
(	NULL
RARa	NULL
)	NULL
.	NULL

*°	NULL
``	NULL
``	NULL
In	NULL
APL	NULL
cells	NULL
,	NULL
the	NULL
characteristic	NULL
PML	NULL
NB	NULL
structures	NULL
are	NULL
absent	NULL
and	NULL
,	NULL
instead	NULL
,	NULL
Blood	NULL
,	NULL
Vol	NULL
88	NULL
,	NULL
No	NULL
4	NULL
(	NULL
August	NULL
15	NULL
)	NULL
,	NULL
1996	NULL
:	NULL
pp	NULL
1423-1436	NULL
structures	NULL
``	NULL
LANDs	NULL
,	NULL
``	NULL
for	NULL
LYSP10O0-associated	NULL
nuclear	NULL
domains	NULL
.	NULL

Although	NULL
LYSP100	NULL
is	NULL
expressed	NULL
only	NULL
in	NULL
lymphoid	NULL
cells	NULL
,	NULL
LANDs	NULL
could	NULL
be	NULL
visualized	NULL
in	NULL
HeLa	NULL
cells	NULL
by	NULL
transfection	NULL
of	NULL
a	NULL
LYSP100	NULL
cDNA	NULL
.	NULL

Immunoelectron	NULL
microscopy	NULL
revealed	NULL
LANDs	NULL
to	NULL
be	NULL
globular	NULL
,	NULL
electron-dense	NULL
structures	NULL
morphologically	NULL
distinct	NULL
from	NULL
the	NULL
annular	NULL
structures	NULL
characteristic	NULL
of	NULL
PML	NULL
NBs	NULL
.	NULL

LANDs	NULL
were	NULL
most	NULL
often	NULL
found	NULL
in	NULL
the	NULL
nucleoplasm	NULL
,	NULL
but	NULL
were	NULL
also	NULL
found	NULL
at	NULL
the	NULL
nuclear	NULL
membrane	NULL
and	NULL
in	NULL
the	NULL
cytoplasm	NULL
,	NULL
suggesting	NULL
that	NULL
these	NULL
structures	NULL
may	NULL
traffic	NULL
between	NULL
the	NULL
cytoplasm	NULL
and	NULL
the	NULL
nucleus	NULL
.	NULL

By	NULL
double-immuno-gold	NULL
labeling	NULL
of	NULL
PML	NULL
and	NULL
LYSP100	NULL
,	NULL
some	NULL
LANDs	NULL
were	NULL
shown	NULL
to	NULL
contain	NULL
both	NULL
PML	NULL
and	NULL
LYSP100	NULL
.	NULL

Thus	NULL
,	NULL
PML	NULL
is	NULL
localized	NULL
to	NULL
a	NULL
second	NULL
subnuclear	NULL
domain	NULL
that	NULL
is	NULL
morphologically	NULL
and	NULL
biochemically	NULL
distinct	NULL
from	NULL
PML	NULL
NBs	NULL
.	NULL

©	NULL
1996	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

PML	NULL
is	NULL
localized	NULL
to	NULL
a	NULL
large	NULL
number	NULL
of	NULL
much	NULL
smaller	NULL
nuclear	NULL
dots	NULL
.	NULL

``	NULL
*	NULL
``	NULL
APL	NULL
patients	NULL
treated	NULL
with	NULL
retinoic	NULL
acid	NULL
undergo	NULL
a	NULL
clinical	NULL
remission	NULL
resulting	NULL
from	NULL
the	NULL
differentiation	NULL
of	NULL
leuke-mic	NULL
cells	NULL
into	NULL
mature	NULL
granulocytes	NULL
and	NULL
a	NULL
concomitant	NULL
decrease	NULL
in	NULL
proliferation	NULL
(	NULL
see	NULL
Grignani	NULL
et	NULL
al	NULL
``	NULL
for	NULL
review	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
treatment	NULL
of	NULL
APL	NULL
cells	NULL
with	NULL
retinoic	NULL
acid	NULL
causes	NULL
reformation	NULL
of	NULL
the	NULL
normal	NULL
PML	NULL
NB	NULL
structures	NULL
,	NULL
leading	NULL
to	NULL
speculation	NULL
that	NULL
disruption	NULL
of	NULL
these	NULL
subnuclear	NULL
domains	NULL
is	NULL
integral	NULL
to	NULL
malignant	NULL
transformation	NULL
by	NULL
PML	NULL
RARa	NULL
.	NULL

``	NULL
*	NULL
Wild-type	NULL
PML	NULL
can	NULL
suppress	NULL
the	NULL
growth	NULL
and	NULL
malignant	NULL
phenotype	NULL
of	NULL
transformed	NULL
cells	NULL
,	NULL
``	NULL
``	NULL
again	NULL
suggesting	NULL
that	NULL
interference	NULL
with	NULL
PML	NULL
function	NULL
might	NULL
contribute	NULL
to	NULL
the	NULL
pathogen-esis	NULL
of	NULL
APL	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
characterized	NULL
a	NULL
novel	NULL
lymphoid-restricted	NULL
protein	NULL
,	NULL
LYSP100	NULL
,	NULL
that	NULL
is	NULL
homologous	NULL
to	NULL
SP100	NULL
,	NULL
a	NULL
protein	NULL
that	NULL
colocalizes	NULL
with	NULL
PML	NULL
in	NULL
PML	NULL
NBs	NULL
.	NULL

SP100	NULL
was	NULL
originally	NULL
defined	NULL
as	NULL
an	NULL
antigen	NULL
detected	NULL
by	NULL
autoantisera	NULL
from	NULL
patients	NULL
with	NULL
primary	NULL
biliary	NULL
cirrhosis	NULL
,	NULL
``	NULL
and	NULL
is	NULL
one	NULL
of	NULL
several	NULL
proteins	NULL
of	NULL
unknown	NULL
function	NULL
that	NULL
are	NULL
found	NULL
in	NULL
PML	NULL
NBs	NULL
.	NULL

>	NULL
``	NULL
°	NULL
Using	NULL
confocal	NULL
microscopy	NULL
and	NULL
EM	NULL
,	NULL
we	NULL
unexpectedly	NULL
found	NULL
that	NULL
LYSP100	NULL
localized	NULL
to	NULL
a	NULL
new	NULL
class	NULL
of	NULL
subnuclear	NULL
structures	NULL
,	NULL
which	NULL
we	NULL
term	NULL
LANDs	NULL
(	NULL
LYSP100-associated	NULL
nuclear	NULL
domains	NULL
)	NULL
,	NULL
that	NULL
are	NULL
morphologically	NULL
and	NULL
spatially	NULL
distinct	NULL
from	NULL
PML	NULL
NBs	NULL
.	NULL

Interestingly	NULL
,	NULL
PML	NULL
colo	NULL
From	NULL
the	NULL
Metabolism	NULL
Branch	NULL
,	NULL
National	NULL
Cancer	NULL
Institute	NULL
,	NULL
and	NULL
the	NULL
Laboratory	NULL
of	NULL
Viral	NULL
Diseases	NULL
,	NULL
National	NULL
Institute	NULL
of	NULL
Allergy	NULL
and	NULL
Infectious	NULL
Diseases	NULL
,	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
;	NULL
CNRS	NULL
UPR	NULL
272	NULL
,	NULL
IRSC	NULL
,	NULL
Villejuif	NULL
;	NULL
and	NULL
CNRS	NULL
UPR	NULL
43	NULL
and	NULL
the	NULL
Department	NULL
of	NULL
Biochemistry	NULL
,	NULL
Hopital	NULL
St	NULL
Louis	NULL
,	NULL
Paris	NULL
,	NULL
France	NULL
.	NULL

Submitted	NULL
January	NULL
5	NULL
,	NULL
1996	NULL
;	NULL
accepted	NULL
April	NULL
8	NULL
,	NULL
1996	NULL
.	NULL

Address	NULL
reprint	NULL
requests	NULL
to	NULL
Louis	NULL
M.	NULL
Staudt	NULL
,	NULL
MD	NULL
,	NULL
PhD	NULL
,	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
Bldg	NULL
10	NULL
,	NULL
Room	NULL
4N114	NULL
,	NULL
9000	NULL
Rockville	NULL
Pike	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
20892	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

©	NULL
1996	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

0006-497	NULL
1/96/8804-0023	NULL
$	NULL
3.00/0	NULL
1423	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1424	NULL
calizes	NULL
with	NULL
LYSP1IOO0	NULL
in	NULL
some	NULL
LANDs	NULL
,	NULL
thus	NULL
defining	NULL
LANDs	NULL
as	NULL
a	NULL
new	NULL
PML-containing	NULL
subnuclear	NULL
structure	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cloning	NULL
of	NULL
LYSP100	NULL
.	NULL

-	NULL
Polymerase	NULL
chain	NULL
reaction	NULL
(	NULL
PCR	NULL
)	NULL
-ampli-fiable	NULL
cDNA	NULL
enriched	NULL
for	NULL
lymphoid-restricted	NULL
genes	NULL
was	NULL
obtained	NULL
by	NULL
subtractive	NULL
hybridization	NULL
of	NULL
cDNA	NULL
from	NULL
the	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
line	NULL
,	NULL
Raji	NULL
,	NULL
with	NULL
mRNA	NULL
from	NULL
the	NULL
erythroleukemia	NULL
line	NULL
,	NULL
K562.°*	NULL
This	NULL
amplified	NULL
cDNA	NULL
was	NULL
used	NULL
to	NULL
construct	NULL
a	NULL
subtracted	NULL
cDNA	NULL
library	NULL
as	NULL
previously	NULL
described	NULL
.	NULL
``	NULL

Twelve	NULL
hundred	NULL
ninety	NULL
clones	NULL
from	NULL
the	NULL
resultant	NULL
subtracted	NULL
library	NULL
were	NULL
sequenced	NULL
by	NULL
automated	NULL
DNA	NULL
sequencing	NULL
and	NULL
evaluated	NULL
for	NULL
homology	NULL
using	NULL
the	NULL
Basic	NULL
Local	NULL
Alignment	NULL
Search	NULL
Tool	NULL
(	NULL
BLAST	NULL
)	NULL
algorithm	NULL
.	NULL

A	NULL
partial	NULL
cDNA	NULL
clone	NULL
,	NULL
AD2511	NULL
,	NULL
was	NULL
found	NULL
to	NULL
have	NULL
high	NULL
homology	NULL
with	NULL
the	NULL
amino-terminal	NULL
region	NULL
of	NULL
SP100	NULL
.	NULL

The	NULL
AD2511	NULL
partial	NULL
LYSP100	NULL
cDNA	NULL
clone	NULL
was	NULL
used	NULL
to	NULL
screen	NULL
a	NULL
large-insert	NULL
Lambda-ZAP	NULL
(	NULL
Stratagene	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
cDNA	NULL
library	NULL
prepared	NULL
from	NULL
the	NULL
Raji	NULL
cell	NULL
line	NULL
.	NULL

cDNA	NULL
library	NULL
screening	NULL
and	NULL
other	NULL
DNA	NULL
manipulations	NULL
were	NULL
performed	NULL
using	NULL
standard	NULL
techniques	NULL
.	NULL
``	NULL

DNA	NULL
sequencing	NULL
was	NULL
performed	NULL
using	NULL
the	NULL
Applied	NULL
Biosystems	NULL
(	NULL
ABI	NULL
;	NULL
Foster	NULL
City	NULL
,	NULL
CA	NULL
)	NULL
373	NULL
Sequencer	NULL
and	NULL
PRISM	NULL
(	NULL
ABI	NULL
)	NULL
sequencing	NULL
mixes	NULL
.	NULL

The	NULL
sequences	NULL
of	NULL
LYSP1I00	NULL
cDNA	NULL
isoforms	NULL
,	NULL
LYSP100-A	NULL
and	NULL
LYSP100-B	NULL
(	NULL
Fig	NULL
2A	NULL
)	NULL
,	NULL
have	NULL
been	NULL
submitted	NULL
to	NULL
Genbank	NULL
and	NULL
assigned	NULL
accession	NULL
numbers	NULL
U36499	NULL
and	NULL
U36500	NULL
,	NULL
respec-tively	NULL
.	NULL

Cloning	NULL
of	NULL
alternate	NULL
SP	NULL
100	NULL
isoforms	NULL
.	NULL

_	NULL
A	NULL
Pstl-Xbal	NULL
fragment	NULL
derived	NULL
from	NULL
LYSP100-A	NULL
,	NULL
which	NULL
has	NULL
sequences	NULL
identical	NULL
to	NULL
the	NULL
LYSP100-B/human	NULL
nuclear	NULL
phosphoprotein	NULL
(	NULL
HNPP	NULL
)	NULL
-like	NULL
domain	NULL
,	NULL
was	NULL
used	NULL
to	NULL
screen	NULL
a	NULL
HeLa	NULL
cDNA	NULL
library	NULL
(	NULL
Stratagene	NULL
)	NULL
.	NULL

A	NULL
2.7-kb	NULL
cDNA	NULL
clone	NULL
obtained	NULL
from	NULL
this	NULL
screen	NULL
,	NULL
termed	NULL
HFPX	NULL
,	NULL
was	NULL
sequenced	NULL
and	NULL
found	NULL
to	NULL
contain	NULL
a	NULL
short	NULL
open	NULL
reading	NULL
frame	NULL
(	NULL
49	NULL
amino	NULL
acids	NULL
)	NULL
with	NULL
very	NULL
high	NULL
homology	NULL
to	NULL
the	NULL
carboxy-terminus	NULL
of	NULL
LYSP100-B	NULL
.	NULL

The	NULL
region	NULL
of	NULL
HFPX	NULL
with	NULL
the	NULL
highest	NULL
homology	NULL
to	NULL
LYSP100-B	NULL
was	NULL
used	NULL
to	NULL
design	NULL
the	NULL
following	NULL
nested	NULL
antisense	NULL
PCR	NULL
primers	NULL
:	NULL
(	NULL
1	NULL
)	NULL
outer	NULL
primer	NULL
,	NULL
S-ATATCCGAATTCCCTTCACCG-CACCACAGGTCAC-3	NULL
'	NULL
,	NULL
and	NULL
(	NULL
2	NULL
)	NULL
inner	NULL
primer	NULL
,	NULL
5'-TGGAAGTAA-AGGAGCCTGAAAATC-3	NULL
'	NULL
.	NULL

These	NULL
primers	NULL
were	NULL
used	NULL
for	NULL
reverse	NULL
transcriptase-PCR	NULL
(	NULL
cDNA	NULL
cycle	NULL
kit	NULL
;	NULL
Invitrogen	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
on	NULL
Raji	NULL
mRNA	NULL
in	NULL
combination	NULL
with	NULL
the	NULL
following	NULL
primers	NULL
from	NULL
the	NULL
3	NULL
``	NULL
end	NULL
of	NULL
SP100	NULL
:	NULL
(	NULL
1	NULL
)	NULL
outer	NULL
primer	NULL
,	NULL
5'-TGGAACGAATTCAGACCT-GAGTAATGGAGAAGAG-3	NULL
'	NULL
,	NULL
and	NULL
(	NULL
2	NULL
)	NULL
inner	NULL
primer	NULL
,	NULL
5-CTTCAG-GAAACCTGCAGCTCATCC-3	NULL
'	NULL
.	NULL

Specificity	NULL
of	NULL
the	NULL
initial	NULL
PCR	NULL
product	NULL
using	NULL
the	NULL
outer	NULL
primers	NULL
was	NULL
verified	NULL
using	NULL
the	NULL
inner	NULL
primers	NULL
.	NULL

A	NULL
400-bp	NULL
product	NULL
from	NULL
the	NULL
initial	NULL
amplification	NULL
was	NULL
digested	NULL
with	NULL
EcoRI	NULL
and	NULL
cloned	NULL
into	NULL
pBluescript	NULL
(	NULL
Stratagene	NULL
)	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
the	NULL
PCR	NULL
product	NULL
showed	NULL
a	NULL
novel	NULL
alternatively	NULL
spliced	NULL
form	NULL
of	NULL
SP100	NULL
,	NULL
and	NULL
the	NULL
subcloned	NULL
PCR	NULL
product	NULL
was	NULL
then	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
to	NULL
screen	NULL
the	NULL
Raji	NULL
cDNA	NULL
library	NULL
described	NULL
earlier	NULL
.	NULL

Four	NULL
independent	NULL
SP100	NULL
cDNA	NULL
clones	NULL
derived	NULL
from	NULL
this	NULL
screen	NULL
were	NULL
analyzed	NULL
,	NULL
and	NULL
all	NULL
four	NULL
clones	NULL
had	NULL
similar	NULL
open	NULL
reading	NULL
frames	NULL
that	NULL
were	NULL
truncated	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
carboxy-terminus	NULL
of	NULL
LYSP100-B	NULL
(	NULL
Fig	NULL
2A	NULL
)	NULL
.	NULL

The	NULL
DNA	NULL
sequence	NULL
of	NULL
the	NULL
SP100-B	NULL
isoform	NULL
has	NULL
been	NULL
submitted	NULL
to	NULL
Genbank	NULL
and	NULL
assigned	NULL
accession	NULL
number	NULL
U36501	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
.	NULL

-	NULL
Human	NULL
cell	NULL
line	NULL
and	NULL
human	NULL
tonsil	NULL
RNAs	NULL
were	NULL
prepared	NULL
and	NULL
enriched	NULL
for	NULL
poly-	NULL
(	NULL
A	NULL
)	NULL
-containing	NULL
mRNA	NULL
selected	NULL
using	NULL
standard	NULL
methods	NULL
.	NULL

Other	NULL
human	NULL
tissue	NULL
mRNAs	NULL
were	NULL
purchased	NULL
from	NULL
Clontech	NULL
(	NULL
Palo	NULL
Alto	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Human	NULL
tonsils	NULL
were	NULL
obtained	NULL
from	NULL
Holy	NULL
Cross	NULL
Hospital	NULL
(	NULL
Silver	NULL
Spring	NULL
,	NULL
MD	NULL
)	NULL
after	NULL
elective	NULL
tonsilecto-mies	NULL
.	NULL

Poly-	NULL
(	NULL
A	NULL
)	NULL
*	NULL
RNA	NULL
(	NULL
2	NULL
ug	NULL
)	NULL
was	NULL
electrophoresed	NULL
on	NULL
a	NULL
1.5	NULL
%	NULL
agarose	NULL
gel	NULL
containing	NULL
formaldehyde	NULL
,	NULL
and	NULL
blotted	NULL
onto	NULL
Hybond-N	NULL
(	NULL
Amer-sham	NULL
,	NULL
Arlington	NULL
Heights	NULL
,	NULL
IL	NULL
)	NULL
.	NULL

DNA	NULL
probes	NULL
were	NULL
labeled	NULL
with	NULL
P-dCTP	NULL
using	NULL
a	NULL
random	NULL
primed	NULL
labeling	NULL
kit	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
,	NULL
Indianapolis	NULL
,	NULL
IN	NULL
)	NULL
.	NULL

The	NULL
LYSP100	NULL
probe	NULL
was	NULL
a	NULL
full-length	NULL
EcoRI-XAol	NULL
LYSP100-A	NULL
cDNA	NULL
fragment	NULL
.	NULL

The	NULL
human	NULL
glyceraldehyde	NULL
phosphate	NULL
dehydrogenase	NULL
(	NULL
GAPDH	NULL
)	NULL
probe	NULL
was	NULL
derived	NULL
by	NULL
reverse	NULL
tran	NULL
DENT	NULL
ET	NULL
AL	NULL
scriptase-PCR	NULL
of	NULL
Raji	NULL
mRNA	NULL
using	NULL
the	NULL
following	NULL
primers	NULL
:	NULL
5°GGG-CGCCTGGTCACCAGGGCTG3	NULL
'	NULL
and	NULL
5	NULL
``	NULL
GGGGCCATCCACAGT-CTTCTG3	NULL
'	NULL
.	NULL

Western	NULL
blotting	NULL
.	NULL

-	NULL
Nuclei	NULL
were	NULL
prepared	NULL
according	NULL
to	NULL
the	NULL
method	NULL
used	NULL
by	NULL
Xie	NULL
et	NULL
al	NULL
,	NULL
``	NULL
and	NULL
whole-cell	NULL
lysates	NULL
were	NULL
prepared	NULL
according	NULL
to	NULL
the	NULL
method	NULL
used	NULL
by	NULL
Sambrook	NULL
et	NULL
al	NULL
.	NULL
``	NULL

''	NULL
Proteins	NULL
were	NULL
separated	NULL
on	NULL
a	NULL
10	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate-polyacrylamide	NULL
gel	NULL
and	NULL
then	NULL
blotted	NULL
onto	NULL
nitrocellulose	NULL
.	NULL

After	NULL
blocking	NULL
with	NULL
2.5	NULL
%	NULL
nonfat	NULL
dry	NULL
milk	NULL
solu-tion	NULL
,	NULL
the	NULL
filter	NULL
was	NULL
incubated	NULL
with	NULL
anti-LYSP100	NULL
antibodies	NULL
at	NULL
1	NULL
ug/	NULL
mL	NULL
.	NULL

Bound	NULL
antibody	NULL
was	NULL
detected	NULL
with	NULL
the	NULL
ECL	NULL
system	NULL
(	NULL
Amer-sham	NULL
)	NULL
.	NULL

Antibodies	NULL
to	NULL
LYSP100	NULL
and	NULL
SP100	NULL
.	NULL

-	NULL
LYSP100	NULL
and	NULL
SP100	NULL
were	NULL
expressed	NULL
in	NULL
bacteria	NULL
using	NULL
the	NULL
pGEX2tk	NULL
vector	NULL
(	NULL
Pharmacia	NULL
,	NULL
Piscata-way	NULL
,	NULL
NJ	NULL
)	NULL
.	NULL

For	NULL
LYSP100	NULL
,	NULL
DNA	NULL
corresponding	NULL
to	NULL
amino	NULL
acids	NULL
306	NULL
to	NULL
412	NULL
of	NULL
the	NULL
A	NULL
form	NULL
was	NULL
amplified	NULL
by	NULL
PCR	NULL
from	NULL
the	NULL
LYSP100-A	NULL
cDNA	NULL
using	NULL
the	NULL
following	NULL
oligonucleotides	NULL
:	NULL
(	NULL
1	NULL
)	NULL
sense	NULL
.	NULL

5'-AAA-AAAGGATCCAAGTCACTAATGAAGGAGAACC-3	NULL
'	NULL
,	NULL
and	NULL
(	NULL
2	NULL
)	NULL
antisense	NULL
,	NULL
5-AAAAAAGAATTCGGAGGATCAGGCAGAAATCC-3	NULL
'	NULL
.	NULL

For	NULL
SP	NULL
100	NULL
,	NULL
DNA	NULL
corresponding	NULL
to	NULL
amino	NULL
acids	NULL
333	NULL
to	NULL
480	NULL
were	NULL
obtained	NULL
by	NULL
reverse	NULL
transcriptase-PCR	NULL
using	NULL
Raji	NULL
mRNA	NULL
and	NULL
the	NULL
following	NULL
oligonucleotides	NULL
:	NULL
(	NULL
1	NULL
)	NULL
sense	NULL
,	NULL
5-AAAAAAGGATCCAGG-TCTGGCCTCCAACTAAGTCTT-3	NULL
'	NULL
,	NULL
and	NULL
(	NULL
2	NULL
)	NULL
antisense	NULL
,	NULL
5'-AAA-AAAGAATTCTCCTGACATTCTGCAGGCCAAGTC-3	NULL
'	NULL
.	NULL

PCR	NULL
products	NULL
were	NULL
digested	NULL
with	NULL
BamHI	NULL
plus	NULL
EcoRI	NULL
before	NULL
cloning	NULL
.	NULL

An	NULL
internal	NULL
BamHI	NULL
site	NULL
in	NULL
the	NULL
SP1IOO	NULL
gene	NULL
(	NULL
at	NULL
amino	NULL
acid	NULL
333	NULL
)	NULL
was	NULL
used	NULL
for	NULL
glutathione-S-transferase	NULL
(	NULL
GST	NULL
)	NULL
cloning	NULL
.	NULL

GST	NULL
alone	NULL
,	NULL
GST-SP100	NULL
,	NULL
and	NULL
GST-LYSP100-A	NULL
proteins	NULL
were	NULL
purified	NULL
by	NULL
standard	NULL
procedures	NULL
.	NULL
``	NULL

Female	NULL
New	NULL
Zealand	NULL
white	NULL
rabbits	NULL
were	NULL
immunized	NULL
with	NULL
a	NULL
primary	NULL
boost	NULL
of	NULL
500	NULL
ug	NULL
soluble	NULL
GST-fusion	NULL
protein	NULL
,	NULL
followed	NULL
by	NULL
an	NULL
initial	NULL
boost	NULL
with	NULL
200	NULL
ug	NULL
protein	NULL
4	NULL
weeks	NULL
later	NULL
plus	NULL
subsequent	NULL
boosts	NULL
every	NULL
2	NULL
weeks	NULL
also	NULL
with	NULL
200	NULL
ug	NULL
protein	NULL
.	NULL

Blood	NULL
samples	NULL
were	NULL
taken	NULL
12	NULL
days	NULL
after	NULL
every	NULL
boost	NULL
.	NULL

GST	NULL
alone	NULL
and	NULL
GST	NULL
-fusion	NULL
proteins	NULL
were	NULL
coupled	NULL
to	NULL
Affigel	NULL
(	NULL
BioRad	NULL
,	NULL
Richmond	NULL
,	NULL
CA	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
specifications	NULL
and	NULL
used	NULL
for	NULL
affinity	NULL
purification	NULL
of	NULL
LYSP100	NULL
and	NULL
SP100	NULL
antibodies	NULL
.	NULL

Briefly	NULL
,	NULL
antiserum	NULL
was	NULL
diluted	NULL
1:5	NULL
in	NULL
10	NULL
mmol/L	NULL
Tris	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
buffer	NULL
and	NULL
passed	NULL
several	NULL
times	NULL
over	NULL
a	NULL
GST-alone	NULL
Affigel	NULL
column	NULL
to	NULL
remove	NULL
anti-GST	NULL
specificities	NULL
.	NULL

Diluted	NULL
antiserum	NULL
was	NULL
next	NULL
passed	NULL
over	NULL
the	NULL
respective	NULL
GST-fusion	NULL
protein	NULL
column	NULL
several	NULL
times	NULL
and	NULL
washed	NULL
extensively	NULL
with	NULL
Tris	NULL
buffer	NULL
.	NULL

Antibodies	NULL
bound	NULL
to	NULL
the	NULL
column	NULL
were	NULL
eluted	NULL
with	NULL
100	NULL
mmol/L	NULL
glycine	NULL
(	NULL
pH	NULL
2.5	NULL
)	NULL
and	NULL
then	NULL
neutralized	NULL
with	NULL
2	NULL
mol/L	NULL
Tris	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
.	NULL

Polyclonal	NULL
mouse	NULL
anti-SP100	NULL
antiserum	NULL
was	NULL
generated	NULL
against	NULL
a	NULL
maltose-bind-ing	NULL
protein-SP100-fusion	NULL
protein	NULL
as	NULL
previously	NULL
described	NULL
.	NULL
``	NULL

''	NULL
Immunofiuorescent	NULL
cell	NULL
staining	NULL
and	NULL
confocal	NULL
microscopy	NULL
.	NULL

-	NULL
The	NULL
Epstein-Barr	NULL
virus-transformed	NULL
human	NULL
B	NULL
lymphoblastoid	NULL
cell	NULL
line	NULL
,	NULL
MBB	NULL
1	NULL
,	NULL
was	NULL
obtained	NULL
from	NULL
Dr	NULL
D.	NULL
Allman	NULL
(	NULL
National	NULL
Cancer	NULL
Institute	NULL
)	NULL
.	NULL

Magnetic	NULL
bead-purified	NULL
(	NULL
Dynal	NULL
Corp	NULL
,	NULL
Lake	NULL
Success	NULL
,	NULL
NY	NULL
)	NULL
CD19	NULL
``	NULL
peripheral	NULL
blood	NULL
B	NULL
lymphocytes	NULL
were	NULL
obtained	NULL
from	NULL
Drs	NULL
T.	NULL
Selvaggi	NULL
and	NULL
W.	NULL
Strober	NULL
(	NULL
National	NULL
Institute	NULL
of	NULL
Allergy	NULL
and	NULL
Infectious	NULL
Dis-eases	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
attached	NULL
to	NULL
glass	NULL
cover	NULL
slips	NULL
coated	NULL
with	NULL
Conca-navalin	NULL
A	NULL
(	NULL
Sigma	NULL
,	NULL
St	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
before	NULL
fixation	NULL
with	NULL
2	NULL
%	NULL
paraform-aldehyde	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
for	NULL
20	NULL
minutes	NULL
at	NULL
25°C	NULL
.	NULL

Cells	NULL
were	NULL
permeabilized	NULL
with	NULL
0.5	NULL
%	NULL
Triton	NULL
X-100	NULL
in	NULL
PBS	NULL
for	NULL
5	NULL
minutes	NULL
at	NULL
25°C	NULL
.	NULL

All	NULL
antibody	NULL
staining	NULL
was	NULL
performed	NULL
at	NULL
25°C	NULL
.	NULL

Rabbit	NULL
antibodies	NULL
were	NULL
used	NULL
at	NULL
1	NULL
to	NULL
2	NULL
pg/mL	NULL
.	NULL

diluted	NULL
in	NULL
PBS	NULL
+	NULL
5	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
+	NULL
0.1	NULL
%	NULL
sodium	NULL
azide	NULL
.	NULL

The	NULL
mouse	NULL
anti-PML	NULL
antibody	NULL
,	NULL
5E10	NULL
,	NULL
``	NULL
was	NULL
obtained	NULL
from	NULL
Dr	NULL
R.	NULL
van	NULL
Driel	NULL
(	NULL
University	NULL
of	NULL
Amster-dam	NULL
,	NULL
the	NULL
Netherlands	NULL
)	NULL
as	NULL
a	NULL
tissue	NULL
culture	NULL
supernatant	NULL
.	NULL

Mouse	NULL
anti-SP100	NULL
serum	NULL
was	NULL
used	NULL
at	NULL
a	NULL
1:100	NULL
dilution	NULL
.	NULL

Fluorescein	NULL
isothiocya-nate-coupled	NULL
donkey	NULL
anti-rabbit	NULL
Ig	NULL
(	NULL
minus	NULL
antimouse	NULL
specificities	NULL
:	NULL
Jackson	NULL
Immunoresearch	NULL
,	NULL
West	NULL
Grove	NULL
,	NULL
PA	NULL
)	NULL
and	NULL
Texas	NULL
Red-coupled	NULL
donkey	NULL
anti-mouse	NULL
Ig	NULL
(	NULL
minus	NULL
antirabbit	NULL
specificities	NULL
;	NULL
Jackson	NULL
Immu-noresearch	NULL
)	NULL
were	NULL
used	NULL
at	NULL
10	NULL
pg/mL	NULL
.	NULL

Stained	NULL
cells	NULL
were	NULL
analyzed	NULL
using	NULL
a	NULL
BioRad	NULL
MRC	NULL
600	NULL
confocal	NULL
laser	NULL
scanning	NULL
microscope	NULL
and	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

NOVEL	NULL
NUCLEAR	NULL
STRUCTURES	NULL
DEFINED	NULL
BY	NULL
LYSP100	NULL
BioRad	NULL
Comos	NULL
software	NULL
.	NULL

Confocal	NULL
images	NULL
were	NULL
merged	NULL
using	NULL
Adobe	NULL
Photoshop	NULL
3.0	NULL
(	NULL
Adobe	NULL
Corp	NULL
,	NULL
Mountain	NULL
View	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Transfection	NULL
of	NULL
HeLa	NULL
cells	NULL
.	NULL

A	NULL
mammalian	NULL
expression	NULL
vector	NULL
for	NULL
LYSP100-B	NULL
was	NULL
created	NULL
by	NULL
cloning	NULL
LYSP100-B	NULL
cDNA	NULL
into	NULL
the	NULL
vector	NULL
pCGN®Y	NULL
as	NULL
follows	NULL
.	NULL

LYSP100-B	NULL
cDNA	NULL
was	NULL
amplified	NULL
by	NULL
PCR	NULL
using	NULL
the	NULL
following	NULL
primers	NULL
:	NULL
AGCAGGGCCAGCAGG3	NULL
'	NULL
and	NULL
S'TTTTTTGGATCCTATTTT-AGGGTGCCATTTGCTGAAT3	NULL
'	NULL
.	NULL

The	NULL
PCR	NULL
product	NULL
was	NULL
digested	NULL
with	NULL
KpnI	NULL
and	NULL
BamHI	NULL
and	NULL
ligated	NULL
into	NULL
the	NULL
same	NULL
sites	NULL
in	NULL
pCGN	NULL
.	NULL

For	NULL
transfection	NULL
,	NULL
HeLa	NULL
cells	NULL
were	NULL
plated	NULL
at	NULL
25	NULL
%	NULL
confluency	NULL
on	NULL
glass	NULL
cover	NULL
slips	NULL
in	NULL
the	NULL
wells	NULL
of	NULL
a	NULL
24-well	NULL
plate	NULL
and	NULL
grown	NULL
in	NULL
Dulbecco	NULL
's	NULL
modified	NULL
essential	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
.	NULL

Cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
CaPO	NULL
,	NULL
procedure	NULL
using	NULL
1	NULL
ug	NULL
pCGN-LYSP100-B	NULL
DNA	NULL
per	NULL
well	NULL
.	NULL

After	NULL
addition	NULL
of	NULL
DNA	NULL
,	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
16	NULL
hours	NULL
at	NULL
37°C	NULL
and	NULL
then	NULL
placed	NULL
in	NULL
fresh	NULL
media	NULL
.	NULL

Cells	NULL
were	NULL
grown	NULL
on	NULL
the	NULL
cover	NULL
slips	NULL
for	NULL
an	NULL
additional	NULL
24	NULL
hours	NULL
before	NULL
staining	NULL
with	NULL
anti-LYSP100	NULL
antibodies	NULL
,	NULL
as	NULL
already	NULL
described	NULL
.	NULL

Immuno-EM	NULL
.	NULL

_	NULL
MBBI	NULL
cell	NULL
cultures	NULL
were	NULL
fixed	NULL
for	NULL
1	NULL
hour	NULL
at	NULL
4°C	NULL
with	NULL
4	NULL
%	NULL
formaldehyde	NULL
in	NULL
0.1	NULL
mol/L	NULL
phosphate	NULL
buffer	NULL
(	NULL
pH	NULL
7.3	NULL
)	NULL
.	NULL

During	NULL
fixation	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
scraped	NULL
from	NULL
the	NULL
plastic	NULL
substratum	NULL
and	NULL
centrifuged	NULL
.	NULL

Pellets	NULL
of	NULL
fixed	NULL
material	NULL
were	NULL
dehydrated	NULL
in	NULL
increasing	NULL
concentrations	NULL
of	NULL
methanol	NULL
and	NULL
embedded	NULL
in	NULL
Lowieryl	NULL
K4M	NULL
(	NULL
Chemische	NULL
Werke	NULL
Lowi	NULL
,	NULL
Waldkraiburg	NULL
,	NULL
Germany	NULL
)	NULL
at	NULL
low	NULL
temperature	NULL
as	NULL
previously	NULL
described	NULL
.	NULL
``	NULL

''	NULL
Polymerization	NULL
was	NULL
performed	NULL
for	NULL
5	NULL
days	NULL
at	NULL
-30°C	NULL
under	NULL
long-wavelength	NULL
UV	NULL
light	NULL
.	NULL

Formvar	NULL
carbon-coated	NULL
copper	NULL
grids	NULL
(	NULL
mesh	NULL
200	NULL
)	NULL
bearing	NULL
ultrathin	NULL
sections	NULL
of	NULL
Lowi-cryl-embedded	NULL
material	NULL
were	NULL
stained	NULL
for	NULL
immunogold	NULL
detection	NULL
by	NULL
first	NULL
incubating	NULL
in	NULL
a	NULL
bovine	NULL
serum	NULL
albumin	NULL
solution	NULL
for	NULL
30	NULL
minutes	NULL
to	NULL
suppress	NULL
nonspecific	NULL
binding	NULL
.	NULL

Grids	NULL
were	NULL
then	NULL
floated	NULL
on	NULL
10-uL	NULL
drops	NULL
of	NULL
an	NULL
LYSP100	NULL
antibody	NULL
solution	NULL
diluted	NULL
to	NULL
10	NULL
Lg/mL	NULL
in	NULL
PBS	NULL
for	NULL
2	NULL
hours	NULL
at	NULL
25°C	NULL
.	NULL

After	NULL
a	NULL
15-minute	NULL
wash	NULL
in	NULL
PBS	NULL
,	NULL
the	NULL
grids	NULL
were	NULL
floated	NULL
for	NULL
30	NULL
minutes	NULL
on	NULL
a	NULL
10-4L	NULL
drop	NULL
of	NULL
a	NULL
1:25	NULL
dilution	NULL
of	NULL
goat	NULL
antirabbit	NULL
IgG	NULL
conjugated	NULL
to	NULL
gold	NULL
particles	NULL
10	NULL
nm	NULL
in	NULL
diameter	NULL
(	NULL
Biocell	NULL
Research	NULL
Laboratories	NULL
,	NULL
Cardiff	NULL
,	NULL
UK	NULL
)	NULL
.	NULL

For	NULL
double	NULL
staining	NULL
,	NULL
uncoated	NULL
grids	NULL
(	NULL
mesh	NULL
300	NULL
)	NULL
were	NULL
first	NULL
stained	NULL
for	NULL
LYSP100	NULL
on	NULL
one	NULL
side	NULL
as	NULL
already	NULL
described	NULL
,	NULL
and	NULL
then	NULL
the	NULL
opposite	NULL
sides	NULL
of	NULL
the	NULL
grids	NULL
were	NULL
stained	NULL
similarly	NULL
for	NULL
PML	NULL
using	NULL
15-nm	NULL
gold	NULL
particle-conjugated	NULL
anti-rabbit	NULL
IgG	NULL
.	NULL

As	NULL
a	NULL
specificity	NULL
control	NULL
for	NULL
the	NULL
immunogold	NULL
labeling	NULL
,	NULL
Hut78	NULL
Jurkat	NULL
HeLa	NULL
K562	NULL
PEC	NULL
:	NULL
Fig	NULL
1	NULL
.	NULL

Expression	NULL
of	NULL
LYSP100	NULL
mRNA	NULL
in	NULL
human	NULL
lymphoid	NULL
cell	NULL
lines	NULL
and	NULL
tissues	NULL
.	NULL

A	NULL
Northern	NULL
blot	NULL
was	NULL
prepared	NULL
using	NULL
2	NULL
ug	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
mRNA	NULL
from	NULL
human	NULL
cell	NULL
lines	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
11	NULL
)	NULL
or	NULL
tissues	NULL
(	NULL
lanes	NULL
12	NULL
to	NULL
17	NULL
)	NULL
and	NULL
hybridized	NULL
with	NULL
a	NULL
radiolabeled	NULL
LYSP100	NULL
probe	NULL
or	NULL
a	NULL
GADPH	NULL
probe	NULL
.	NULL

Cell	NULL
lines	NULL
:	NULL
HeLa	NULL
,	NULL
cervical	NULL
carcinoma	NULL
;	NULL
K562	NULL
,	NULL
_	NULL
myeloerythroleukemia	NULL
;	NULL
Hut78	NULL
and	NULL
Jurkat	NULL
,	NULL
T	NULL
cell	NULL
;	NULL
Nalm6	NULL
,	NULL
pre-B	NULL
cell	NULL
;	NULL
and	NULL
Raji	NULL
,	NULL
BJAB	NULL
,	NULL
MBB1	NULL
,	NULL
VDSO	NULL
,	NULL
WIL2-NS	NULL
,	NULL
and	NULL
ARHKH77	NULL
,	NULL
mature	NULL
B	NULL
cell	NULL
.	NULL

LYSP100	NULL
%	NULL
1425	NULL
all	NULL
steps	NULL
were	NULL
performed	NULL
normally	NULL
but	NULL
the	NULL
primary	NULL
antibody	NULL
was	NULL
omitted	NULL
.	NULL

RESULTS	NULL
LYSP100	NULL
gene	NULL
characterization	NULL
.	NULL

-	NULL
In	NULL
an	NULL
effort	NULL
to	NULL
identify	NULL
novel	NULL
lymphoid-restricted	NULL
transcription	NULL
factors	NULL
,	NULL
we	NULL
combined	NULL
subtractive	NULL
cDNA	NULL
methodology	NULL
with	NULL
random	NULL
automated	NULL
DNA	NULL
sequencing	NULL
.	NULL

A	NULL
subtracted	NULL
cDNA	NULL
library	NULL
was	NULL
prepared	NULL
that	NULL
was	NULL
enriched	NULL
for	NULL
genes	NULL
expressed	NULL
in	NULL
the	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
cell	NULL
line	NULL
,	NULL
Raji	NULL
,	NULL
and	NULL
not	NULL
in	NULL
the	NULL
erythroleukemia	NULL
cell	NULL
line	NULL
,	NULL
K562	NULL
.	NULL
``	NULL

One	NULL
subtracted	NULL
cDNA	NULL
clone	NULL
was	NULL
chosen	NULL
for	NULL
study	NULL
by	NULL
virtue	NULL
of	NULL
its	NULL
homology	NULL
with	NULL
an	NULL
autoantigen	NULL
,	NULL
$	NULL
P100	NULL
,	NULL
°°	NULL
``	NULL
that	NULL
had	NULL
been	NULL
previously	NULL
localized	NULL
to	NULL
PML	NULL
NB	NULL
subnuclear	NULL
domains	NULL
.	NULL
``	NULL

Northern	NULL
blot	NULL
analysis	NULL
showed	NULL
that	NULL
this	NULL
gene	NULL
was	NULL
expressed	NULL
as	NULL
three	NULL
major	NULL
mRNA	NULL
transcripts	NULL
,	NULL
0.9	NULL
,	NULL
1.6	NULL
,	NULL
and	NULL
3.0	NULL
kb	NULL
in	NULL
length	NULL
,	NULL
that	NULL
were	NULL
detected	NULL
in	NULL
all	NULL
three	NULL
lymphoid	NULL
tissues	NULL
examined	NULL
(	NULL
spleen	NULL
,	NULL
thymus	NULL
,	NULL
and	NULL
tonsil	NULL
)	NULL
but	NULL
not	NULL
in	NULL
three	NULL
nonlymphoid	NULL
tissues	NULL
(	NULL
Fig	NULL
1	NULL
)	NULL
.	NULL

LYSP100	NULL
mRNA	NULL
was	NULL
expressed	NULL
in	NULL
all	NULL
mature	NULL
B-lymphocyte	NULL
and	NULL
plasma	NULL
cell	NULL
lines	NULL
tested	NULL
(	NULL
Fig	NULL
1	NULL
,	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
but	NULL
it	NULL
was	NULL
only	NULL
variably	NULL
expressed	NULL
in	NULL
T-lymphocyte	NULL
lines	NULL
and	NULL
was	NULL
not	NULL
detectable	NULL
in	NULL
several	NULL
nonlymphoid	NULL
cell	NULL
lines	NULL
(	NULL
Fig	NULL
1	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
gene	NULL
is	NULL
thus	NULL
lymphoid-restricted	NULL
both	NULL
in	NULL
human	NULL
tissues	NULL
and	NULL
in	NULL
cell	NULL
lines	NULL
.	NULL

Consequently	NULL
,	NULL
we	NULL
named	NULL
this	NULL
gene	NULL
LYSP100	NULL
,	NULL
for	NULL
lymphoid-restricted	NULL
homologue	NULL
of	NULL
SP100	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
SP100	NULL
expression	NULL
is	NULL
widespread	NULL
``	NULL
``	NULL
*	NULL
``	NULL
``	NULL
(	NULL
and	NULL
AL	NULL
.	NULL

Dent	NULL
,	NULL
unpublished	NULL
results	NULL
,	NULL
January	NULL
1994	NULL
)	NULL
.	NULL

To	NULL
isolate	NULL
full-length	NULL
LYSP100	NULL
cDNAs	NULL
,	NULL
a	NULL
Raji	NULL
cDNA	NULL
library	NULL
was	NULL
screened	NULL
with	NULL
the	NULL
partial	NULL
LYSP100	NULL
cDNA	NULL
,	NULL
and	NULL
two	NULL
cDNA	NULL
clones	NULL
,	NULL
both	NULL
3.0	NULL
kb	NULL
long	NULL
,	NULL
were	NULL
chosen	NULL
for	NULL
further	NULL
analysis	NULL
(	NULL
Fig	NULL
2A	NULL
)	NULL
.	NULL

The	NULL
sequences	NULL
of	NULL
LYSP100-A	NULL
and	NULL
LYSP100-B	NULL
cDNAs	NULL
have	NULL
identical	NULL
5	NULL
``	NULL
and	NULL
3	NULL
'	NULL
sequences	NULL
but	NULL
differ	NULL
by	NULL
two	NULL
short	NULL
insertions	NULL
in	NULL
the	NULL
middle	NULL
of	NULL
the	NULL
LYSP100-B	NULL
cDNA	NULL
,	NULL
which	NULL
probably	NULL
result	NULL
from	NULL
alternative	NULL
splicing	NULL
.	NULL

>	NULL
w	NULL
r	NULL
o	NULL
c	NULL
3	NULL
tO	NULL
-	NULL
O	NULL
Zon	NULL
~	NULL
0	NULL
=	NULL
E	NULL
.c	NULL
®	NULL
-	NULL
S5	NULL
5	NULL
;	NULL
8	NULL
E0	NULL
5s	NULL
£	NULL
23	NULL
a	NULL
5	NULL
8	NULL
0	NULL
52	NULL
aisorc	NULL
=7.5	NULL
kb	NULL
=2.4	NULL
kb	NULL
6	NULL
0	NULL
#	NULL
s	NULL
a	NULL
f	NULL
=1.4	NULL
kb	NULL
»	NULL
tis	NULL
=0.2	NULL
kb	NULL
GADPH—m	NULL
'	NULL
ﬁ	NULL
Qﬁ	NULL
.	NULL

&	NULL
#	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
1011	NULL
121314151617	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1426	NULL
DENT	NULL
ET	NULL
AL	NULL
A	NULL
LYSP100	NULL
-A	NULL
LYSP100-B	NULL
SP100-A	NULL
SP100-B	NULL
LYSP100	NULL
-A	NULL
LYSP100-B	NULL
LAMRPKAGGG	NULL
QAQARTHE	NULL
VECQAQARTHH	NULL
]	NULL
LYSP100	NULL
-A	NULL
LYSP100-B	NULL
SP100-A	NULL
SP100-B	NULL
HNPP1	NULL
P	NULL
e	NULL
NS	NULL
S	NULL
o	NULL
~	NULL
Sia	NULL
TECARK	NULL
[	NULL
EI	NULL
I	NULL
DGTSEMNECGKRSOK§	NULL
@	NULL
E	NULL
;	NULL
faz	NULL
sa	NULL
cH	NULL
CK	NULL
KCIQTEL	NULL
p	NULL
Eai	NULL
§	NULL
&	NULL
:	NULL
InRgle	NULL
-	NULL
-	NULL
§	NULL
:	NULL
kKakBices	NULL
vore	NULL
ap	NULL
peee	NULL
doar	NULL
a	NULL
in-	NULL
f	NULL
-	NULL
(	NULL
atv	NULL
T	NULL
1	NULL
————————————————————————	NULL
``	NULL
I	NULL
~f	NULL
a	NULL
appara-	NULL
Lysrioo-a	NULL
IMM	NULL
_	NULL
]	NULL
HNPP	NULL
|	NULL
___	NULL
S4	NULL
_	NULL
sPr100-B	NULL
|N	NULL
xm	NULL
LYSP100-B	NULL
Hlllllllllﬂllllllll	NULL
755515553	NULL
Ss	NULL
[	NULL
1	NULL
_d	NULL
I	NULL
PHD/	NULL
Bromo-LYSP100/SP100	NULL
TTC	NULL
-	NULL
domain	NULL
Homology	NULL
Regions	NULL
Domain	NULL
Fig	NULL
2	NULL
.	NULL

Amino	NULL
acid	NULL
sequence	NULL
of	NULL
LYSP100	NULL
and	NULL
comparison	NULL
to	NULL
SP100	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Two	NULL
LYSP100	NULL
protein	NULL
isoforms	NULL
aligned	NULL
with	NULL
2	NULL
SP100	NULL
protein	NULL
isoforms	NULL
and	NULL
HNPP1	NULL
(	NULL
Genbank	NULL
accession	NULL
no	NULL
.	NULL

L22343	NULL
)	NULL
.	NULL

Identical	NULL
amino	NULL
acids	NULL
are	NULL
in	NULL
black	NULL
and	NULL
conservative	NULL
amino	NULL
acid	NULL
changes	NULL
in	NULL
grey	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Schematic	NULL
representation	NULL
of	NULL
regions	NULL
of	NULL
high	NULL
sequence	NULL
homology	NULL
between	NULL
LYSP100	NULL
isoforms	NULL
,	NULL
SP100	NULL
isoforms	NULL
,	NULL
and	NULL
HNPP1	NULL
.	NULL

Striped	NULL
boxes	NULL
indicate	NULL
regions	NULL
in	NULL
LYSP100	NULL
,	NULL
$	NULL
P100	NULL
,	NULL
and	NULL
HNPP	NULL
with	NULL
high	NULL
amino	NULL
acid	NULL
similarity	NULL
.	NULL

Additional	NULL
regions	NULL
of	NULL
similarity	NULL
within	NULL
these	NULL
proteins	NULL
include	NULL
the	NULL
PHD/TTC	NULL
domain	NULL
(	NULL
#	NULL
)	NULL
and	NULL
the	NULL
bromodomain	NULL
(	NULL
checkered	NULL
box	NULL
)	NULL
.	NULL

Other	NULL
LYSP100	NULL
cDNAs	NULL
account	NULL
for	NULL
the	NULL
0.9-	NULL
and	NULL
1.6-kb	NULL
with	NULL
the	NULL
amino-terminal	NULL
region	NULL
of	NULL
a	NULL
previously	NULL
described	NULL
mRNAs	NULL
and	NULL
are	NULL
also	NULL
most	NULL
likely	NULL
the	NULL
products	NULL
of	NULL
alternative	NULL
SP100	NULL
cDNA	NULL
isoform	NULL
``	NULL
(	NULL
termed	NULL
SP100-A	NULL
in	NULL
Fig	NULL
2A	NULL
and	NULL
splicing	NULL
(	NULL
A.L.D	NULL
.	NULL

,	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
insertions	NULL
in	NULL
the	NULL
B	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
additional	NULL
400	NULL
amino	NULL
acids	NULL
found	NULL
in	NULL
LYSP100-B	NULL
cDNA	NULL
alter	NULL
the	NULL
size	NULL
of	NULL
the	NULL
predicted	NULL
open	NULL
read-	NULL
LYSP100-B	NULL
but	NULL
not	NULL
in	NULL
LYSP100-A	NULL
showed	NULL
significant	NULL
ho-ing	NULL
frame	NULL
:	NULL
LYSP100-A	NULL
encodes	NULL
a	NULL
protein	NULL
of	NULL
412	NULL
amino	NULL
acids	NULL
mology	NULL
with	NULL
another	NULL
previously	NULL
cloned	NULL
protein	NULL
,	NULL
HNPP	NULL
(	NULL
Fig	NULL
with	NULL
a	NULL
molecular	NULL
weight	NULL
of	NULL
46	NULL
kD	NULL
,	NULL
whereas	NULL
LYSP100-B	NULL
2A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

HNPP	NULL
is	NULL
highly	NULL
inducible	NULL
by	NULL
interferon	NULL
but	NULL
has	NULL
encodes	NULL
a	NULL
protein	NULL
of	NULL
882	NULL
amino	NULL
acids	NULL
with	NULL
a	NULL
molecular	NULL
no	NULL
known	NULL
function	NULL
.	NULL
``	NULL

weight	NULL
of	NULL
100	NULL
kD	NULL
.	NULL

The	NULL
amino-terminal	NULL
158	NULL
residues	NULL
of	NULL
both	NULL
To	NULL
identify	NULL
potential	NULL
SP100	NULL
cDNA	NULL
isoforms	NULL
that	NULL
encoded	NULL
LYSP100	NULL
protein	NULL
isoforms	NULL
have	NULL
61	NULL
%	NULL
amino	NULL
acid	NULL
homology	NULL
a	NULL
HNPP	NULL
domain	NULL
,	NULL
we	NULL
screened	NULL
a	NULL
HeLa	NULL
cDNA	NULL
library	NULL
using	NULL
a	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

NOVEL	NULL
NUCLEAR	NULL
STRUCTURES	NULL
DEFINED	NULL
BY	NULL
LYSP100	NULL
1427	NULL
LYSP100-8	NULL
_	NULL
-	NULL
-	NULL
--	NULL
-	NULL
--	NULL
-	NULL
--	NULL
-	NULL
--	NULL
-	NULL
--	NULL
-	NULL
U	NULL
734	NULL
TFI	NULL
-	NULL
-	NULL
LQUBBL	NULL
T	NULL
BRAY	NULL
838	NULL
MLL1	NULL
Q	NULL
-	NULL
-	NULL
VIgc	NULL
E	NULL
PIBIK	NULL
FIL	NULL
EENERP	NULL
LGDQLEN	NULL
--	NULL
--	NULL
--	NULL
--	NULL
-	NULL
1480	NULL
MLL-2	NULL
N	NULL
-	NULL
-	NULL
KSR	NULL
N	NULL
S	NULL
G	NULL
(	NULL
L	NULL
GN	NULL
Y	NULL
P	NULL
T	NULL
KP	NULL
TKKKKV	NULL
--	NULL
-	NULL
--	NULL
--	NULL
-	NULL
-W	NULL
I	NULL
[	NULL
qT	NULL
K	NULL
(	NULL
@	NULL
v	NULL
iss	NULL
MLL-3	NULL
G	NULL
-	NULL
-	NULL
KiDGwVvbIs	NULL
K	NULL
[	NULL
@	NULL
ENL	NULL
SDEMY	NULL
[	NULL
G	NULL
I	NULL
LSNL	NULL
PESVA	NULL
--	NULL
--	NULL
--	NULL
--	NULL
-	NULL
Buc	NULL
v	NULL
ECL	NULL
MLL-4	NULL
R	NULL
[	NULL
eJF	NULL
[	NULL
QK	NULL
P-	NULL
-	NULL
--	NULL
-	NULL
--	NULL
-	NULL
--	NULL
-	NULL
--	NULL
-	NULL
A	NULL
T	NULL
V	NULL
GIgC	NULL
L	NULL
T	NULL
MIGS	NULL
R	NULL
AKNCV	NULL
F	NULL
LDDKK	NULL
--	NULL
--	NULL
v	NULL
v	NULL
[	NULL
€	NULL
R	NULL
HG	NULL
]	NULL
trx-d	NULL
L	NULL
[	NULL
oF	NULL
SGS	NULL
TL	NULL
D	NULL
--	NULL
--	NULL
-	NULL
--	NULL
-	NULL
--	NULL
-	NULL
-	NULL
Pi	NULL
Flea	NULL
--	NULL
25	NULL
trx-2	NULL
(	NULL
Q	NULL
-	NULL
-	NULL
TL	NULL
GTSKRLLGADRP	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
-	NULL
trx-3	NULL
a-	NULL
-	NULL
pleécowvhisk	NULL
[	NULL
@	NULL
EGLSDEYNLLSTLPES	NULL
I	NULL
E	NULL
--	NULL
--	NULL
trx-4	NULL
NV	NULL
RGeG	NULL
E	NULL
HR	NULL
[	NULL
IBIY	NULL
P	NULL
[	NULL
eARS	NULL
I	NULL
DCAFL	NULL
TDKS	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
BR140-1	NULL
-	NULL
-	NULL
MIgNL	NULL
I	NULL
PEGQ	NULL
--	NULL
=	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
321	NULL
BR140-2	NULL
HKANYY	NULL
T	NULL
AGbJV	NULL
T	NULL
{	NULL
eaQQAGL	NULL
IHT	NULL
-	NULL
448	NULL
hCBP	NULL
F	NULL
T	NULL
E	NULL
I	NULL
QGENV	NULL
T	NULL
L	NULL
--	NULL
X	NULL
2	NULL
7	NULL
-	NULL
-	NULL
P	NULL
F	NULL
V	NULL
-	NULL
-	NULL
E	NULL
[	NULL
eGEIK	NULL
MDKe	NULL
)	NULL
I	NULL
[	NULL
(	NULL
V	NULL
[	NULL
MH	NULL
Y	NULL
D	NULL
1	NULL
1WPSG	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
-	NULL
1283	NULL
mCBP	NULL
T	NULL
E	NULL
I	NULL
QGENVTL	NULL
--	NULL
X	NULL
2	NULL
7	NULL
-	NULL
-	NULL
P	NULL
F	NULL
V	NULL
-	NULL
-	NULL
E	NULL
(	NULL
e	NULL
iin	NULL
yo	NULL
i	NULL
iwesa-	NULL
[	NULL
eL	NULL
1289	NULL
p300	NULL
FGk	NULL
{	NULL
grneiocEsvsL	NULL
--	NULL
X27	NULL
--	NULL
LFVE	NULL
Theeg	NULL
HHEI	NULL
FVDGL	NULL
1252	NULL
PHD/TTC	NULL
Domain	NULL
LYSP100-B	NULL
MKESEGSQQCQ	NULL
—————————	NULL
EEVERQC	NULL
[	NULL
SE	NULL
mK	NULL
c	NULL
EL	NULL
L	NULL
LV	NULL
v	NULL
Cels	NULL
)	NULL
774	NULL
TIF	NULL
D	NULL
L	NULL
S	NULL
K	NULL
[	NULL
JE	NULL
v	NULL
D	NULL
v	NULL
[	NULL
gD	NULL
v	NULL
P	NULL
S	NULL
H	NULL
H	NULL
S	NULL
E	NULL
K	NULL
R	NULL
K	NULL
Mt	NULL
-	NULL
[	NULL
#	NULL
1	NULL
[	NULL
]	NULL
|	NULL
(	NULL
)	NULL
x	NULL
n	NULL
[	NULL
esh	NULL
r	NULL
em	NULL
887	NULL
LYSP100-B	NULL
SSFFAKIYIHELKEPM	NULL
L	NULL
DK	NULL
1	NULL
KKR	NULL
L	NULL
NE	NULL
H	NULL
[	NULL
efi®y	NULL
PQV	NULL
EGF	NULL
V	NULL
QDMR	NULL
L	NULL
|	NULL
F	NULL
QNGIR	NULL
A	NULL
Sv	NULL
essa	NULL
aie	NULL
Fld	NULL
n	NULL
L	NULL
E	NULL
A	NULL
E	NULL
F	NULL
(	NULL
RES	NULL
TIF	NULL
s	NULL
1	NULL
Eigo	NULL
o	NULL
PW	NULL
-	NULL
[	NULL
)	NULL
-	NULL
-	NULL
L	NULL
T	NULL
UP	NULL
y	NULL
v	NULL
K	NULL
1	NULL
Tis	NULL
1	NULL
v	NULL
c	NULL
mpt	NULL
k	NULL
P	NULL
[	NULL
JD	NULL
Aa	NULL
IF	NULL
EARARGENIc	NULL
a	NULL
e	NULL
-n-	NULL
eros	NULL
evan	NULL
ald	NULL
1	NULL
os4	NULL
dFSH-2	NULL
AW	NULL
P	NULL
P	NULL
YD	NULL
a	NULL
E	NULL
m	NULL
L	NULL
GWH	NULL
(	NULL
aly	NULL
H	NULL
o	NULL
1	NULL
o	NULL
fie	NULL
t	NULL
nre	NULL
-	NULL
-	NULL
fik	NULL
s	NULL
a	NULL
p	NULL
cda	NULL
a	NULL
c	NULL
yk	NULL
-n	NULL
v	NULL
s	NULL
hFSH-2	NULL
AWP	NULL
EAFK	NULL
P	NULL
JD	NULL
A	NULL
S	NULL
A	NULL
L	NULL
Gln	NULL
aly	NULL
H	NULL
o	NULL
1	NULL
t	NULL
MECSECOE	NULL
nR	NULL
o	NULL
-	NULL
-in	NULL
o	NULL
ade	NULL
(	NULL
da	NULL
yk	NULL
v	NULL
vig	NULL
see	NULL
ORFX-2	NULL
AW	NULL
P	NULL
EAgk	NULL
P	NULL
JD	NULL
A	NULL
E	NULL
A	NULL
L	NULL
E	NULL
(	NULL
MH	NULL
(	NULL
aly	NULL
H	NULL
o	NULL
1	NULL
ofis	NULL
t	NULL
cn	NULL
e	NULL
-	NULL
-	NULL
Yio	NULL
a	NULL
fda	NULL
a	NULL
PIs	NULL
(	NULL
cy	NULL
k	NULL
aflan	NULL
(	NULL
@	NULL
iReov	NULL
[	NULL
g	NULL
40s	NULL
dFSH-1	NULL
swe	NULL
o	NULL
o	NULL
Po	NULL
a	NULL
k	NULL
K	NULL
L	NULL
NMP	NULL
iy	NULL
h	NULL
k	NULL
1	NULL
Mc	NULL
t	NULL
APEX	NULL
nn	NULL
v	NULL
-	NULL
-	NULL
faws	NULL
a	NULL
K	NULL
€	NULL
T	NULL
[	NULL
Rep	NULL
)	NULL
Novy	NULL
133	NULL
hFSH-1	NULL
AwP	NULL
lir	NULL
o	NULL
P	NULL
D	NULL
a	NULL
v	NULL
K	NULL
L	NULL
ily	NULL
H	NULL
k	NULL
1	NULL
Mc	NULL
t	NULL
nn	NULL
v	NULL
-	NULL
-	NULL
faw	NULL
a	NULL
a	NULL
s	NULL
&	NULL
c	NULL
(	NULL
ep	NULL
)	NULL
iG	NULL
12s	NULL
ORFX-1	NULL
Awp	NULL
ago	NULL
p	NULL
Mo	NULL
a	NULL
1	NULL
k	NULL
L	NULL
(	NULL
ay	NULL
Hk	NULL
1	NULL
Ns	NULL
ovi	NULL
ig	NULL
133	NULL
p300	NULL
si	NULL
L	NULL
r	NULL
o	NULL
|	NULL
Mi	NULL
awl	NULL
evid	NULL
i149	NULL
hCBP	NULL
si	NULL
plinoriolde	NULL
L	NULL
L	NULL
F	NULL
o	NULL
1	NULL
Ms	NULL
#	NULL
185	NULL
mCBP	NULL
s	NULL
i	NULL
L	NULL
Lclipfy	NULL
r	NULL
o	NULL
|	NULL
MB	NULL
i185	NULL
BDF1-1	NULL
AR	NULL
pL	NULL
o	NULL
p	NULL
Moy	NULL
k	NULL
c	NULL
o	NULL
ile	NULL
Fv	NULL
F	NULL
n	NULL
v	NULL
OBs	NULL
Us	NULL
ik-	NULL
@	NULL
n-crnagi	NULL
24s	NULL
BDF1-2	NULL
n	NULL
v	NULL
pL	NULL
e	NULL
s	NULL
mnie	NULL
t	NULL
v	NULL
F	NULL
o	NULL
v	NULL
MGA	NULL
Mo	NULL
(	NULL
ic	NULL
t	NULL
(	NULL
Céﬂ—N—PDGTIVNM	NULL
41s	NULL
GCNsS	NULL
-	NULL
-	NULL
ke	NULL
v	NULL
o	NULL
r	NULL
MO	NULL
t	NULL
(	NULL
D	NULL
v	NULL
rq	NULL
424	NULL
BR140	NULL
on	NULL
is	NULL
ep-	NULL
c	NULL
o	NULL
F	NULL
F	NULL
Tt	NULL
Mp3	NULL
Acik-un-akoti	NULL
@	NULL
rraav	NULL
@	NULL
ilre®s	NULL
72	NULL
ccat-1	NULL
T	NULL
v	NULL
pnp	NULL
(	NULL
-	NULL
-	NULL
n	NULL
A	NULL
K	NULL
v	NULL
(	NULL
ROY	NULL
v	NULL
K	NULL
1	NULL
[	NULL
0	NULL
1477	NULL
ccar-2	NULL
swe	NULL
[	NULL
gh	NULL
h	NULL
PM-	NULL
-	NULL
N	NULL
K	NULL
K	NULL
GAP	NULL
)	NULL
y	NULL
v	NULL
kv	NULL
(	NULL
svk-n-cresofitktaoefilvnvc	NULL
1500	NULL
SPT7	NULL
spp	NULL
N	NULL
@	NULL
I	NULL
--	NULL
sKREAPNY	NULL
HG	NULL
]	NULL
1	NULL
1	NULL
Alfekks	NULL
sso	NULL
BRAHMA	NULL
sepak	NULL
L	NULL
-	NULL
-s	NULL
ronfp®y	NULL
v	NULL
[	NULL
31	NULL
|	NULL
affiekvg	NULL
1523	NULL
hBRG1	NULL
sevii	NULL
ou	NULL
vg	NULL
i	NULL
1s2s	NULL
hBRM	NULL
sevgi	NULL
ou	NULL
Macy	NULL
|	NULL
v	NULL
(	NULL
MeBv®q	NULL
1495	NULL
SNF2	NULL
s	NULL
p	NULL
|	NULL
L	NULL
-s	NULL
k	NULL
a	NULL
L	NULL
Y	NULL
Ply	NULL
v	NULL
m	NULL
1	NULL
N	NULL
T	NULL
T	NULL
L	NULL
a	NULL
-	NULL
-	NULL
in	NULL
s	NULL
ik	NULL
e	NULL
t	NULL
op	NULL
)	NULL
r	NULL
n	NULL
-n-	NULL
tecsvyvygosce	NULL
(	NULL
Mgkvyv	NULL
1648	NULL
STH1	NULL
tg	NULL
:	NULL
FkVv	NULL
nc	NULL
t	NULL
-	NULL
tige	NULL
t	NULL
-Un-eecswyvyvoaof	NULL
@	NULL
iinert	NULL
1343	NULL
PB1-1	NULL
cel	NULL
|	NULL
ra	NULL
-	NULL
-k	NULL
yv	NULL
Us	NULL
me	NULL
e	NULL
-	NULL
-	NULL
fo	NULL
olin	NULL
v	NULL
c	NULL
t	NULL
agr	NULL
-krposreykaac	NULL
@	NULL
iiweLpm	NULL
44s	NULL
PB1-2	NULL
se	NULL
Gok	NULL
L-	NULL
-As	NULL
vay	NULL
rily	NULL
v	NULL
a	NULL
|	NULL
0	NULL
(	NULL
Mk	NULL
t	NULL
fla	NULL
oic	NULL
no	NULL
t	NULL
-	NULL
-	NULL
{	NULL
k	NULL
s	NULL
[	NULL
iH	NULL
a	NULL
m	NULL
a	NULL
x	NULL
(	NULL
o	NULL
(	NULL
an	NULL
A-N—EPGSOVFKDANAKKI	NULL
277	NULL
PB1-3	NULL
se	NULL
pge	NULL
-	NULL
-fs	NULL
kkk	NULL
v	NULL
ry	NULL
(	NULL
0s	NULL
[	NULL
i	NULL
kn	NULL
@	NULL
e	NULL
-	NULL
-pe	NULL
t	NULL
Me	NULL
i	NULL
478	NULL
PB1-4	NULL
co	NULL
Lignv	NULL
[	NULL
g-	NULL
-s	NULL
k	NULL
k	NULL
o	NULL
v	NULL
Pldy	NULL
v	NULL
K	NULL
1	NULL
L	NULL
Go	NULL
@	NULL
x	NULL
uble	NULL
n	NULL
nfin	NULL
no	NULL
k	NULL
-	NULL
-	NULL
fv	NULL
c	NULL
eGa	NULL
mugo	NULL
Ota	NULL
Taran	NULL
yno	NULL
anmiigk	NULL
1	NULL
L_	NULL
s16	NULL
PB1-5	NULL
s	NULL
i	NULL
(	NULL
@	NULL
c	NULL
a	NULL
c	NULL
-	NULL
-s	NULL
a	NULL
s	NULL
e	NULL
@	NULL
e	NULL
)	NULL
y	NULL
v	NULL
1	NULL
1	NULL
DEK	NULL
(	NULL
AYO	NULL
MBROGs	NULL
H	NULL
[	NULL
fiv	NULL
a	NULL
n	NULL
k	NULL
-	NULL
-	NULL
(	NULL
o	NULL
ofiE	NULL
)	NULL
s	NULL
v	NULL
(	NULL
Mina	NULL
ii	NULL
ykoalvilinkvL	NULL
754	NULL
Bromodomain	NULL
Fig	NULL
2	NULL
.	NULL

(	NULL
cont	NULL
'd	NULL
)	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Alignments	NULL
of	NULL
the	NULL
PHD/TTC	NULL
domain	NULL
and	NULL
bromodomain	NULL
of	NULL
LYSP100-B	NULL
with	NULL
other	NULL
PHD/TTC-	NULL
and/or	NULL
bromodomain-containing	NULL
proteins	NULL
from	NULL
the	NULL
database	NULL
.	NULL

The	NULL
spacer	NULL
region	NULL
between	NULL
PHD/TTC	NULL
domains	NULL
and	NULL
bromodomains	NULL
of	NULL
LYSP100-B	NULL
and	NULL
TIF1	NULL
are	NULL
also	NULL
aligned	NULL
to	NULL
show	NULL
the	NULL
similarity	NULL
in	NULL
this	NULL
region	NULL
between	NULL
the	NULL
2	NULL
proteins	NULL
.	NULL

Identical	NULL
amino	NULL
acids	NULL
and	NULL
highly	NULL
conservative	NULL
amino	NULL
acid	NULL
substitutions	NULL
compared	NULL
with	NULL
LYSP100-B	NULL
are	NULL
in	NULL
black	NULL
.	NULL

References	NULL
or	NULL
accession	NULL
numbers	NULL
for	NULL
the	NULL
protein	NULL
sequences	NULL
:	NULL
TIF1**	NULL
;	NULL
MLL	NULL
,	NULL
Q03164	NULL
(	NULL
SP	NULL
)	NULL
;	NULL
trx	NULL
,	NULL
P20659	NULL
(	NULL
SP	NULL
)	NULL
;	NULL
BR140	NULL
,	NULL
M91585	NULL
(	NULL
GB	NULL
)	NULL
;	NULL
hCBP	NULL
,	NULL
$	NULL
39162	NULL
(	NULL
PIR	NULL
)	NULL
;	NULL
mCBP	NULL
,	NULL
$	NULL
39161	NULL
(	NULL
PIR	NULL
)	NULL
;	NULL
p300	NULL
,	NULL
UO1877	NULL
(	NULL
GB	NULL
)	NULL
;	NULL
dFSH	NULL
,	NULL
P13709	NULL
(	NULL
SP	NULL
)	NULL
;	NULL
hFSH	NULL
,	NULL
X62083	NULL
(	NULL
GB	NULL
)	NULL
;	NULL
ORFX	NULL
,	NULL
D26362	NULL
(	NULL
GB	NULL
)	NULL
;	NULL
BDF1	NULL
,	NULL
Z218944	NULL
(	NULL
GB	NULL
)	NULL
;	NULL
GCNS	NULL
,	NULL
Q03330	NULL
(	NULL
SP	NULL
)	NULL
;	NULL
CCG1	NULL
,	NULL
P21675	NULL
(	NULL
SP	NULL
)	NULL
;	NULL
SPT7	NULL
,	NULL
L22537	NULL
(	NULL
GB	NULL
)	NULL
;	NULL
BRAHMA	NULL
,	NULL
P25439	NULL
(	NULL
SP	NULL
)	NULL
;	NULL
hBRG1	NULL
,	NULL
S66910	NULL
(	NULL
GB	NULL
)	NULL
;	NULL
hBRM	NULL
,	NULL
X72889	NULL
(	NULL
GB	NULL
)	NULL
;	NULL
SNF2	NULL
,	NULL
P22082	NULL
(	NULL
SP	NULL
)	NULL
;	NULL
STH1	NULL
,	NULL
M83755	NULL
(	NULL
GB	NULL
)	NULL
;	NULL
and	NULL
PB1	NULL
,	NULL
X90849	NULL
(	NULL
GB	NULL
)	NULL
.	NULL

SP	NULL
,	NULL
Swiss	NULL
protein	NULL
;	NULL
GB	NULL
,	NULL
GenBank	NULL
.	NULL

probe	NULL
derived	NULL
from	NULL
the	NULL
LYSP100-B	NULL
HNPP	NULL
homology	NULL
region	NULL
.	NULL

Based	NULL
on	NULL
the	NULL
sequence	NULL
of	NULL
a	NULL
novel	NULL
-like	NULL
clone	NULL
isolated	NULL
from	NULL
this	NULL
screen	NULL
,	NULL
PCR	NULL
primers	NULL
were	NULL
designed	NULL
that	NULL
were	NULL
used	NULL
with	NULL
SP100	NULL
primers	NULL
to	NULL
amplify	NULL
a	NULL
novel	NULL
SP100	NULL
isoform	NULL
from	NULL
Raji	NULL
cDNA	NULL
.	NULL

Sequencing	NULL
of	NULL
a	NULL
full-length	NULL
cDNA	NULL
for	NULL
this	NULL
SP100	NULL
isoform	NULL
,	NULL
termed	NULL
SP100-B	NULL
,	NULL
revealed	NULL
that	NULL
it	NULL
is	NULL
identical	NULL
to	NULL
SP100-A	NULL
over	NULL
the	NULL
first	NULL
477	NULL
amino	NULL
acids	NULL
,	NULL
but	NULL
it	NULL
has	NULL
a	NULL
carboxy-terminal	NULL
extension	NULL
that	NULL
is	NULL
highly	NULL
similar	NULL
to	NULL
but	NULL
shorter	NULL
than	NULL
the	NULL
carboxy-terminal	NULL
domain	NULL
of	NULL
LYSP100-B	NULL
(	NULL
Fig	NULL
2A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
LYSP100-B	NULL
and	NULL
SP100-B	NULL
iso-	NULL
forms	NULL
share	NULL
amino	NULL
acid	NULL
similarity	NULL
throughout	NULL
the	NULL
length	NULL
of	NULL
the	NULL
predicted	NULL
proteins	NULL
(	NULL
Fig	NULL
2B	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
these	NULL
two	NULL
proteins	NULL
had	NULL
a	NULL
common	NULL
evolutionary	NULL
precursor	NULL
.	NULL

Further	NULL
sequence	NULL
analysis	NULL
of	NULL
the	NULL
LYSP100-B	NULL
isoform	NULL
revealed	NULL
two	NULL
additional	NULL
domains	NULL
found	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
transcriptional	NULL
regulatory	NULL
proteins	NULL
:	NULL
a	NULL
PHD/TTC	NULL
domain'**	NULL
'	NULL
and	NULL
a	NULL
bromodomain*	NULL
``	NULL
(	NULL
Fig	NULL
2B	NULL
and	NULL
C	NULL
)	NULL
.	NULL

The	NULL
PHD/TTC	NULL
domain	NULL
is	NULL
a	NULL
cysteine-rich	NULL
motif	NULL
with	NULL
the	NULL
general	NULL
structure	NULL
,	NULL
C	NULL
,	NULL
HC	NULL
;	NULL
,	NULL
that	NULL
is	NULL
presumed	NULL
to	NULL
coordinate	NULL
zinc	NULL
.	NULL

Interestingly	NULL
,	NULL
like	NULL
LYSP100	NULL
B	NULL
,	NULL
several	NULL
coactivator	NULL
proteins	NULL
contain	NULL
both	NULL
a	NULL
PHD/TTC	NULL
domain	NULL
and	NULL
a	NULL
bromodomain	NULL
,	NULL
including	NULL
TIF1	NULL
,	NULL
*	NULL
``	NULL
CREB	NULL
binding	NULL
factor	NULL
,	NULL
``	NULL
and	NULL
p300	NULL
.	NULL

*	NULL
The	NULL
PHD/TTC	NULL
domain	NULL
and	NULL
bromodomain	NULL
of	NULL
LYSP100-B	NULL
are	NULL
most	NULL
closely	NULL
related	NULL
to	NULL
those	NULL
of	NULL
TIF1	NULL
,	NULL
a	NULL
potential	NULL
transcriptional	NULL
coactivator	NULL
for	NULL
nuclear	NULL
hormone	NULL
receptors	NULL
.	NULL
``	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
spacer	NULL
regions	NULL
between	NULL
PHD/TTC	NULL
domains	NULL
and	NULL
bromodomains	NULL
of	NULL
LYSP100-B	NULL
and	NULL
TIFI	NULL
are	NULL
similar	NULL
in	NULL
length	NULL
and	NULL
have	NULL
homology	NULL
to	NULL
each	NULL
other	NULL
(	NULL
Fig	NULL
2C	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
carboxy	NULL
termini	NULL
of	NULL
these	NULL
two	NULL
proteins	NULL
may	NULL
have	NULL
related	NULL
functions	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
PHD/TTC	NULL
domain	NULL
and	NULL
bromodomain	NULL
in	NULL
LYSP100-B	NULL
suggests	NULL
that	NULL
LYSP100-B	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
transcriptional	NULL
regulation	NULL
.	NULL

Subcellular	NULL
localization	NULL
of	NULL
LYSP100	NULL
protein	NULL
.	NULL

We	NULL
next	NULL
generated	NULL
_-	NULL
affinity-purified	NULL
-	NULL
rabbit	NULL
-	NULL
antibodies	NULL
-	NULL
against	NULL
LYSP100	NULL
to	NULL
determine	NULL
if	NULL
LYSP100	NULL
,	NULL
like	NULL
SP100	NULL
,	NULL
was	NULL
localized	NULL
in	NULL
PML	NULL
NBs	NULL
.	NULL

The	NULL
anti-LYSP100	NULL
antibodies	NULL
were	NULL
raised	NULL
against	NULL
the	NULL
carboxy	NULL
terminus	NULL
of	NULL
LYSP100-A	NULL
,	NULL
since	NULL
this	NULL
region	NULL
displayed	NULL
little	NULL
homology	NULL
to	NULL
SP100	NULL
.	NULL

These	NULL
anti	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1428	NULL
Nuclear	NULL
Whole	NULL
Cell	NULL
Extract	NULL
-	NULL
Extract	NULL
(	NULL
=	NULL
R	NULL
LC	NULL
-	NULL
(	NULL
£3	NULL
L	NULL
£	NULL
C	NULL
G	NULL
in	NULL
C	NULL
_	NULL
o	NULL
T	NULL
C	NULL
Y	NULL
<	NULL
C	NULL
-100	NULL
kD	NULL
-69	NULL
kD	NULL
-46	NULL
kD	NULL
-30	NULL
kD	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
Fig	NULL
3	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
of	NULL
LYSP100	NULL
protein	NULL
.	NULL

Nuclear	NULL
or	NULL
whole-cell	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
B-cell	NULL
lines	NULL
expressing	NULL
LYSP100	NULL
mRNA	NULL
(	NULL
ARH77	NULL
and	NULL
Raji	NULL
)	NULL
or	NULL
from	NULL
cell	NULL
lines	NULL
lacking	NULL
LYSP100	NULL
mRNA	NULL
(	NULL
K562	NULL
and	NULL
Reh	NULL
)	NULL
and	NULL
analyzed	NULL
by	NULL
immunoblotting	NULL
with	NULL
affinity-purified	NULL
anti-LYSP100	NULL
antibodies	NULL
.	NULL

Arrows	NULL
indicate	NULL
multiple	NULL
LYSP100	NULL
protein	NULL
isoforms	NULL
.	NULL

LYSP100	NULL
antibodies	NULL
should	NULL
also	NULL
recognize	NULL
the	NULL
LYSP100-B	NULL
isoform	NULL
,	NULL
since	NULL
most	NULL
of	NULL
the	NULL
LYSP100-A	NULL
carboxy	NULL
terminus	NULL
is	NULL
shared	NULL
by	NULL
LYSP100-B	NULL
(	NULL
Fig	NULL
2A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

Specificity	NULL
of	NULL
the	NULL
anti-LYSP100	NULL
antibodies	NULL
was	NULL
tested	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
of	NULL
nuclear	NULL
and	NULL
whole-cell	NULL
extracts	NULL
(	NULL
Fig	NULL
3	NULL
)	NULL
.	NULL

A	NULL
set	NULL
of	NULL
protein	NULL
isoforms	NULL
was	NULL
observed	NULL
in	NULL
cells	NULL
that	NULL
express	NULL
LYSP	NULL
100	NULL
mRNA	NULL
(	NULL
ARH77	NULL
and	NULL
Raji	NULL
)	NULL
,	NULL
but	NULL
not	NULL
in	NULL
cells	NULL
lacking	NULL
LYSP	NULL
100	NULL
mRNA	NULL
(	NULL
K562	NULL
and	NULL
REH	NULL
)	NULL
.	NULL

The	NULL
LYSP100	NULL
isoforms	NULL
ranged	NULL
in	NULL
size	NULL
from	NULL
65	NULL
to	NULL
150	NULL
kD	NULL
and	NULL
may	NULL
represent	NULL
the	NULL
products	NULL
of	NULL
alternatively	NULL
spliced	NULL
LYSP100	NULL
mRNAs	NULL
or	NULL
may	NULL
include	NULL
proteolytic	NULL
degradation	NULL
products	NULL
.	NULL

In	NULL
vitro	NULL
translation	NULL
of	NULL
LYSP100-A	NULL
and	NULL
LYSP100-B	NULL
isoforms	NULL
showed	NULL
that	NULL
the	NULL
protein	NULL
products	NULL
migrate	NULL
more	NULL
slowly	NULL
in	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
gels	NULL
than	NULL
predicted	NULL
by	NULL
the	NULL
DNA	NULL
sequence	NULL
,	NULL
as	NULL
previously	NULL
observed	NULL
for	NULL
SP100*°	NULL
(	NULL
and	NULL
A.L.D	NULL
.	NULL

,	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

By	NULL
this	NULL
criterion	NULL
,	NULL
LYSP100-A	NULL
mRNA	NULL
can	NULL
account	NULL
for	NULL
the	NULL
65-kD	NULL
LYSP100	NULL
protein	NULL
isoform	NULL
seen	NULL
on	NULL
Western	NULL
blots	NULL
,	NULL
and	NULL
LYSP100-B	NULL
mRNA	NULL
can	NULL
account	NULL
for	NULL
the	NULL
150-kD	NULL
LYSP100	NULL
protein	NULL
iso-form	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
100-kD	NULL
LYSP100	NULL
protein	NULL
appears	NULL
to	NULL
be	NULL
encoded	NULL
by	NULL
another	NULL
LSYP100	NULL
cDNA	NULL
isoform	NULL
(	NULL
A.L.D	NULL
.	NULL

,	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
lower-molecular-weight	NULL
bands	NULL
on	NULL
the	NULL
Western	NULL
blots	NULL
were	NULL
detected	NULL
in	NULL
all	NULL
cells	NULL
regardless	NULL
of	NULL
LYSP100	NULL
mRNA	NULL
levels	NULL
,	NULL
and	NULL
therefore	NULL
represent	NULL
cross-reacting	NULL
protein	NULL
species	NULL
(	NULL
Fig	NULL
3	NULL
)	NULL
.	NULL

Next	NULL
,	NULL
subcellular	NULL
localization	NULL
of	NULL
LYSP100	NULL
was	NULL
investigated	NULL
using	NULL
the	NULL
affinity-purified	NULL
anti-LYSP100	NULL
antibodies	NULL
for	NULL
immunofluorescent	NULL
staining	NULL
and	NULL
confocal	NULL
laser	NULL
microscopy	NULL
of	NULL
the	NULL
MBBI1	NULL
human	NULL
lymphoblastoid	NULL
cell	NULL
line	NULL
and	NULL
human	NULL
peripheral	NULL
blood	NULL
B	NULL
lymphocytes	NULL
(	NULL
Fig	NULL
4	NULL
)	NULL
.	NULL

LYSP	NULL
100	NULL
localized	NULL
to	NULL
five	NULL
to	NULL
20	NULL
dot-like	NULL
structures	NULL
in	NULL
the	NULL
nucleus	NULL
of	NULL
MBBI1	NULL
cells	NULL
(	NULL
Fig	NULL
4A	NULL
,	NULL
D	NULL
,	NULL
and	NULL
G	NULL
)	NULL
.	NULL

LYSP100-associated	NULL
dots	NULL
were	NULL
also	NULL
detected	NULL
in	NULL
nontransformed	NULL
human	NULL
peripheral	NULL
blood	NULL
B	NULL
cells	NULL
(	NULL
Fig	NULL
41	NULL
,	NULL
3	NULL
cells	NULL
shown	NULL
)	NULL
.	NULL

On	NULL
average	NULL
,	NULL
the	NULL
number	NULL
of	NULL
LYSP100-associated	NULL
dots	NULL
was	NULL
significantly	NULL
lower	NULL
in	NULL
peripheral	NULL
blood	NULL
DENT	NULL
ET	NULL
AL	NULL
B	NULL
cells	NULL
than	NULL
in	NULL
the	NULL
Epstein-Barr	NULL
virus-transformed	NULL
cell	NULL
line	NULL
:	NULL
one	NULL
to	NULL
three	NULL
structures	NULL
were	NULL
seen	NULL
per	NULL
peripheral	NULL
blood	NULL
B	NULL
cell	NULL
,	NULL
with	NULL
some	NULL
cells	NULL
having	NULL
no	NULL
detectable	NULL
dots	NULL
.	NULL

LYSP100	NULL
was	NULL
detected	NULL
in	NULL
nuclear	NULL
dots	NULL
regardless	NULL
of	NULL
whether	NULL
the	NULL
cells	NULL
were	NULL
fixed	NULL
with	NULL
paraformaldehyde	NULL
,	NULL
methanol	NULL
,	NULL
or	NULL
acetone	NULL
,	NULL
and	NULL
nuclear	NULL
localization	NULL
of	NULL
LYSP100	NULL
dots	NULL
was	NULL
confirmed	NULL
by	NULL
costaining	NULL
the	NULL
cells	NULL
with	NULL
a	NULL
dye	NULL
specific	NULL
for	NULL
DNA	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Specificity	NULL
of	NULL
LYSP100	NULL
staining	NULL
was	NULL
demonstrated	NULL
in	NULL
two	NULL
ways	NULL
.	NULL

First	NULL
,	NULL
the	NULL
characteristic	NULL
LYSP100	NULL
nuclear	NULL
dots	NULL
were	NULL
found	NULL
only	NULL
in	NULL
LYSP100-expressing	NULL
cells	NULL
(	NULL
MBBI1	NULL
,	NULL
VDSO	NULL
,	NULL
and	NULL
ARH77	NULL
)	NULL
,	NULL
and	NULL
not	NULL
in	NULL
cells	NULL
that	NULL
are	NULL
negative	NULL
for	NULL
LYSP100	NULL
mRNA	NULL
(	NULL
K562	NULL
and	NULL
HeLa	NULL
)	NULL
(	NULL
A.L.D	NULL
.	NULL

,	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

As	NULL
a	NULL
second	NULL
test	NULL
of	NULL
antibody	NULL
specificity	NULL
,	NULL
HeLa	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
a	NULL
eukaryotic	NULL
expression	NULL
vector	NULL
for	NULL
LYSP100-B	NULL
and	NULL
then	NULL
costained	NULL
with	NULL
the	NULL
anti-LYSP	NULL
100	NULL
antibodies	NULL
(	NULL
Fig	NULL
5A	NULL
,	NULL
green	NULL
staining	NULL
)	NULL
and	NULL
with	NULL
the	NULL
5E10	NULL
monoclonal	NULL
anti-PML	NULL
antibody	NULL
(	NULL
Fig	NULL
5A	NULL
,	NULL
red	NULL
staining	NULL
)	NULL
.	NULL

Ten	NULL
percent	NULL
to	NULL
20	NULL
%	NULL
of	NULL
the	NULL
cells	NULL
showed	NULL
a	NULL
dot-like	NULL
nuclear	NULL
staining	NULL
with	NULL
anti-LYSP100	NULL
antibodies	NULL
that	NULL
was	NULL
similar	NULL
to	NULL
the	NULL
LYSP100	NULL
staining	NULL
observed	NULL
in	NULL
MBBI1	NULL
lymphoblastoid	NULL
cells	NULL
.	NULL

Nuclear	NULL
localization	NULL
of	NULL
LYSP100	NULL
dots	NULL
was	NULL
confirmed	NULL
by	NULL
Nomarski	NULL
differential-interference	NULL
contrast	NULL
microscopy	NULL
(	NULL
Fig	NULL
5B	NULL
)	NULL
.	NULL

The	NULL
remainder	NULL
of	NULL
the	NULL
cells	NULL
,	NULL
which	NULL
presumably	NULL
did	NULL
not	NULL
incorporate	NULL
DNA	NULL
during	NULL
the	NULL
transfection	NULL
,	NULL
did	NULL
not	NULL
show	NULL
this	NULL
LYSP100	NULL
staining	NULL
pattern	NULL
.	NULL

These	NULL
specificity	NULL
studies	NULL
demonstrate	NULL
that	NULL
although	NULL
anti-LYSP100	NULL
antibodies	NULL
detected	NULL
minor	NULL
cross-reacting	NULL
protein	NULL
species	NULL
in	NULL
all	NULL
cell	NULL
types	NULL
by	NULL
Western	NULL
blot	NULL
analy-sis	NULL
,	NULL
these	NULL
cross-reacting	NULL
proteins	NULL
were	NULL
not	NULL
readily	NULL
detectable	NULL
in	NULL
the	NULL
immunofluorescence	NULL
assay	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
HeLa	NULL
transfection	NULL
experiment	NULL
demonstrates	NULL
that	NULL
LYSP	NULL
100	NULL
nuclear	NULL
structures	NULL
can	NULL
be	NULL
generated	NULL
in	NULL
nonlymphoid	NULL
cells	NULL
and	NULL
thus	NULL
do	NULL
not	NULL
require	NULL
other	NULL
lymphoid-specific	NULL
proteins	NULL
for	NULL
their	NULL
for-mation	NULL
.	NULL

Surprisingly	NULL
,	NULL
in	NULL
transfected	NULL
HeLa	NULL
cells	NULL
,	NULL
LYSP100	NULL
and	NULL
PML	NULL
staining	NULL
patterns	NULL
were	NULL
largely	NULL
nonoverlapping	NULL
(	NULL
Fig	NULL
5A	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
the	NULL
majority	NULL
of	NULL
LYSP100	NULL
and	NULL
PML	NULL
nuclear	NULL
structures	NULL
in	NULL
MBBI1	NULL
and	NULL
peripheral	NULL
blood	NULL
B	NULL
cells	NULL
were	NULL
not	NULL
coincident	NULL
(	NULL
Fig	NULL
4C	NULL
,	NULL
F	NULL
,	NULL
I	NULL
,	NULL
and	NULL
L	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
SP	NULL
100	NULL
and	NULL
PML	NULL
colocalized	NULL
precisely	NULL
in	NULL
MBBI1	NULL
cells	NULL
in	NULL
nuclear	NULL
structures	NULL
with	NULL
the	NULL
characteristic	NULL
appearance	NULL
of	NULL
PML	NULL
NBs	NULL
(	NULL
Fig	NULL
4M	NULL
to	NULL
O	NULL
)	NULL
,	NULL
confirming	NULL
previous	NULL
results	NULL
.	NULL

We	NULL
next	NULL
tested	NULL
whether	NULL
the	NULL
LYSP100	NULL
nuclear	NULL
dots	NULL
coincided	NULL
with	NULL
other	NULL
previously	NULL
described	NULL
subnuclear	NULL
domains	NULL
.	NULL

LYSP100	NULL
immunofluorescent	NULL
staining	NULL
was	NULL
entirely	NULL
nonoverlapping	NULL
with	NULL
the	NULL
nuclear	NULL
speckles	NULL
detected	NULL
with	NULL
antibodies	NULL
to	NULL
the	NULL
splicing	NULL
factor	NULL
,	NULL
SC35	NULL
,	NULL
``	NULL
°	NULL
and	NULL
the	NULL
nuclear	NULL
dots	NULL
detected	NULL
with	NULL
antibodies	NULL
to	NULL
p80-coilin	NULL
``	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
LYSP100	NULL
was	NULL
localized	NULL
to	NULL
subnuclear	NULL
structures	NULL
that	NULL
are	NULL
distinguishable	NULL
from	NULL
PML	NULL
NBs	NULL
,	NULL
interchromatin	NULL
granules	NULL
and	NULL
interchromatin	NULL
fibrils	NULL
(	NULL
containing	NULL
SC35	NULL
)	NULL
,	NULL
and	NULL
coiled	NULL
bodies	NULL
(	NULL
containing	NULL
p80-coi-lin	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
in	NULL
approximately	NULL
5	NULL
%	NULL
of	NULL
the	NULL
MBBI1	NULL
cells	NULL
,	NULL
PML	NULL
dots	NULL
and	NULL
LYSP100	NULL
dots	NULL
exactly	NULL
coincided	NULL
within	NULL
a	NULL
confocal	NULL
optical	NULL
slice	NULL
(	NULL
Fig	NULL
4C	NULL
and	NULL
I	NULL
)	NULL
.	NULL

In	NULL
some	NULL
cells	NULL
,	NULL
only	NULL
one	NULL
dot	NULL
costained	NULL
for	NULL
LYSP100	NULL
and	NULL
PML	NULL
(	NULL
Fig	NULL
4C	NULL
)	NULL
,	NULL
whereas	NULL
in	NULL
other	NULL
cells	NULL
LYSP100	NULL
and	NULL
PML	NULL
coincided	NULL
in	NULL
more	NULL
than	NULL
one	NULL
structure	NULL
(	NULL
Fig	NULL
41	NULL
)	NULL
.	NULL

In	NULL
some	NULL
cells	NULL
,	NULL
the	NULL
pattern	NULL
of	NULL
PML/	NULL
LYSP100	NULL
colocalization	NULL
was	NULL
also	NULL
striking	NULL
,	NULL
in	NULL
that	NULL
the	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

NOVEL	NULL
NUCLEAR	NULL
STRUCTURES	NULL
DEFINED	NULL
BY	NULL
LYSP100	NULL
1429	NULL
Fig	NULL
4	NULL
.	NULL

Laser-scanning	NULL
confocal	NULL
microscopy	NULL
of	NULL
cells	NULL
immuno-fluorescently	NULL
stained	NULL
with	NULL
antibodies	NULL
to	NULL
LYSP100	NULL
and/or	NULL
PML	NULL
(	NULL
A	NULL
to	NULL
L	NULL
)	NULL
or	NULL
with	NULL
antibodies	NULL
to	NULL
$	NULL
P100	NULL
and/or	NULL
PML	NULL
(	NULL
M	NULL
to	NULL
0	NULL
}	NULL
.	NULL

A	NULL
to	NULL
I	NULL
and	NULL
M	NULL
to	NULL
O	NULL
were	NULL
derived	NULL
from	NULL
the	NULL
human	NULL
lymphoblastoid	NULL
cell	NULL
line	NULL
,	NULL
MBB1	NULL
,	NULL
with	NULL
each	NULL
row	NULL
representing	NULL
images	NULL
obtained	NULL
from	NULL
a	NULL
single	NULL
MBB1	NULL
cell	NULL
.	NULL

J	NULL
to	NULL
L	NULL
were	NULL
derived	NULL
from	NULL
human	NULL
peripheral	NULL
blood	NULL
B	NULL
lymphocytes	NULL
.	NULL

Three	NULL
representative	NULL
cells	NULL
are	NULL
shown	NULL
in	NULL
each	NULL
panel	NULL
.	NULL

Green	NULL
fluorescence	NULL
(	NULL
LYSP100	NULL
or	NULL
SP100	NULL
)	NULL
and	NULL
red	NULL
fluorescence	NULL
(	NULL
PML	NULL
)	NULL
were	NULL
collected	NULL
simultaneously	NULL
and	NULL
then	NULL
separated	NULL
and	NULL
merged	NULL
digitally	NULL
.	NULL

Colocalization	NULL
of	NULL
green	NULL
and	NULL
red	NULL
fluorescence	NULL
yields	NULL
a	NULL
yellow	NULL
image	NULL
.	NULL

LYSP	NULL
100	NULL
SP	NULL
100	NULL
PML	NULL
MERGE	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

Fig	NULL
6	NULL
.	NULL

Laser-scanning	NULL
confocal	NULL
fluorescent	NULL
microscopy	NULL
z-series	NULL
of	NULL
a	NULL
MBB1	NULL
cell	NULL
stained	NULL
with	NULL
anti-LYSP100-B	NULL
antibody	NULL
(	NULL
green	NULL
fluorescence	NULL
)	NULL
and	NULL
anti-PML	NULL
antibody	NULL
(	NULL
red	NULL
fluorescence	NULL
)	NULL
.	NULL

Twenty	NULL
optical	NULL
slices	NULL
along	NULL
the	NULL
z-axis	NULL
are	NULL
shown	NULL
.	NULL

.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

NOVEL	NULL
NUCLEAR	NULL
STRUCTURES	NULL
DEFINED	NULL
BY	NULL
LYSP100	NULL
1431	NULL
Fig	NULL
5	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Laser-scanning	NULL
confocal	NULL
fluorescent	NULL
microscopy	NULL
of	NULL
HeLa	NULL
cells	NULL
transfected	NULL
with	NULL
a	NULL
LYSP100-B	NULL
expression	NULL
vector	NULL
and	NULL
then	NULL
stained	NULL
with	NULL
anti-LYSP100-B	NULL
antibody	NULL
(	NULL
green	NULL
fluorescence	NULL
)	NULL
and	NULL
anti-PML	NULL
antibody	NULL
(	NULL
red	NULL
fluorescence	NULL
)	NULL
.	NULL

At	NULL
left	NULL
is	NULL
a	NULL
binucleated	NULL
transfected	NULL
cell	NULL
,	NULL
and	NULL
at	NULL
right	NULL
are	NULL
several	NULL
nontransfected	NULL
cells	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Nomarski	NULL
differential-interference	NULL
contrast	NULL
microscopy	NULL
of	NULL
the	NULL
cells	NULL
in	NULL
A.	NULL
LYSP100	NULL
immunofluorescence	NULL
appeared	NULL
to	NULL
be	NULL
surrounded	NULL
by	NULL
a	NULL
ring	NULL
of	NULL
PML	NULL
immunofluorescence	NULL
(	NULL
Fig	NULL
41	NULL
)	NULL
.	NULL

Based	NULL
on	NULL
an	NULL
analysis	NULL
of	NULL
a	NULL
z-series	NULL
of	NULL
20	NULL
confocal	NULL
optical	NULL
slices	NULL
through	NULL
this	NULL
cell	NULL
(	NULL
Fig	NULL
6	NULL
)	NULL
,	NULL
PML	NULL
appeared	NULL
to	NULL
form	NULL
a	NULL
shell	NULL
around	NULL
a	NULL
central	NULL
LYSP100	NULL
core	NULL
.	NULL

This	NULL
observation	NULL
rules	NULL
out	NULL
the	NULL
possibility	NULL
that	NULL
colocalization	NULL
of	NULL
LYSP100	NULL
and	NULL
PML	NULL
in	NULL
these	NULL
structures	NULL
occurred	NULL
simply	NULL
by	NULL
chance	NULL
superimposition	NULL
.	NULL

Next	NULL
,	NULL
the	NULL
relationship	NULL
of	NULL
SP100	NULL
dots	NULL
to	NULL
LYSP1OO0	NULL
dots	NULL
was	NULL
judged	NULL
by	NULL
costaining	NULL
with	NULL
a	NULL
polyclonal	NULL
mouse	NULL
anti-SP100	NULL
antibody	NULL
and	NULL
the	NULL
polyclonal	NULL
rabbit	NULL
anti-LYSP100	NULL
antibody	NULL
(	NULL
Fig	NULL
7	NULL
)	NULL
.	NULL

In	NULL
most	NULL
cells	NULL
,	NULL
SP100	NULL
and	NULL
LYSP100	NULL
were	NULL
detected	NULL
in	NULL
nuclear	NULL
dots	NULL
that	NULL
did	NULL
not	NULL
overlap	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

However	NULL
,	NULL
in	NULL
some	NULL
cells	NULL
dot-like	NULL
structures	NULL
containing	NULL
both	NULL
SP100	NULL
and	NULL
LYSP100	NULL
were	NULL
detected	NULL
,	NULL
and	NULL
often	NULL
a	NULL
single	NULL
nucleus	NULL
contained	NULL
several	NULL
such	NULL
structures	NULL
(	NULL
Fig	NULL
7	NULL
)	NULL
.	NULL

Approximately	NULL
the	NULL
same	NULL
minor	NULL
fraction	NULL
of	NULL
MBBI1	NULL
cells	NULL
(	NULL
~5	NULL
%	NULL
)	NULL
showed	NULL
LYSP100/SP100	NULL
colocalization	NULL
as	NULL
showed	NULL
LYSP100/PML	NULL
colocalization	NULL
.	NULL

Thus	NULL
,	NULL
in	NULL
a	NULL
minority	NULL
of	NULL
cells	NULL
,	NULL
LYSP100	NULL
colocalized	NULL
with	NULL
PML	NULL
or	NULL
$	NULL
P100	NULL
.	NULL

In	NULL
some	NULL
images	NULL
,	NULL
the	NULL
colocalization	NULL
was	NULL
reminiscent	NULL
of	NULL
PML	NULL
NBs	NULL
(	NULL
Fig	NULL
41	NULL
)	NULL
.	NULL

However	NULL
,	NULL
a	NULL
more	NULL
precise	NULL
definition	NULL
of	NULL
LYSP100-associated	NULL
nuclear	NULL
structures	NULL
required	NULL
the	NULL
higher	NULL
resolution	NULL
afforded	NULL
by	NULL
immuno-EM	NULL
.	NULL

Immuno-EM	NULL
characterization	NULL
of	NULL
LANDs	NULL
.	NULL

-	NULL
We	NULL
used	NULL
immuno-EM	NULL
to	NULL
visualize	NULL
the	NULL
ultrastructural	NULL
morphology	NULL
and	NULL
subcellular	NULL
localization	NULL
of	NULL
LYSP10O-associated	NULL
structures	NULL
.	NULL

After	NULL
fixation	NULL
and	NULL
embedding	NULL
of	NULL
MBBI1	NULL
lymphoblastoid	NULL
cells	NULL
,	NULL
thin	NULL
sections	NULL
were	NULL
reacted	NULL
with	NULL
LYSP100	NULL
antibodies	NULL
alone	NULL
(	NULL
Fig	NULL
8	NULL
)	NULL
,	NULL
with	NULL
both	NULL
LYSP100	NULL
and	NULL
PML	NULL
antibodies	NULL
(	NULL
Fig	NULL
9	NULL
)	NULL
,	NULL
or	NULL
with	NULL
both	NULL
LYSP100	NULL
and	NULL
SP100	NULL
antibodies	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

LYSP100	NULL
antibodies	NULL
were	NULL
secondarily	NULL
reacted	NULL
with	NULL
anti-rabbit	NULL
IgG	NULL
antibodies	NULL
coupled	NULL
to	NULL
10-nm	NULL
gold	NULL
particles	NULL
,	NULL
whereas	NULL
PML	NULL
or	NULL
SP100	NULL
antibodies	NULL
were	NULL
detected	NULL
with	NULL
antibodies	NULL
coupled	NULL
to	NULL
15-nm	NULL
gold	NULL
particles	NULL
.	NULL

LYSP100	NULL
antibodies	NULL
decorated	NULL
electron-dense	NULL
structures	NULL
that	NULL
were	NULL
round	NULL
to	NULL
irregular	NULL
in	NULL
shape	NULL
.	NULL

These	NULL
structures	NULL
ranged	NULL
from	NULL
0.1	NULL
to	NULL
0.3	NULL
um	NULL
in	NULL
diameter	NULL
,	NULL
and	NULL
thus	NULL
were	NULL
smaller	NULL
than	NULL
PML	NULL
NBs	NULL
,	NULL
which	NULL
were	NULL
0.3	NULL
to	NULL
1.0	NULL
wm	NULL
.	NULL

The	NULL
electron	NULL
density	NULL
of	NULL
LYSP100-associated	NULL
structures	NULL
was	NULL
often	NULL
uneven	NULL
,	NULL
and	NULL
in	NULL
many	NULL
instances	NULL
they	NULL
appeared	NULL
to	NULL
have	NULL
a	NULL
central	NULL
core	NULL
that	NULL
was	NULL
more	NULL
electron-dense	NULL
(	NULL
Figs	NULL
8A	NULL
and	NULL
9A	NULL
)	NULL
.	NULL

Specificity	NULL
of	NULL
LYSP100	NULL
immunogold	NULL
detection	NULL
was	NULL
checked	NULL
in	NULL
two	NULL
ways	NULL
.	NULL

First	NULL
,	NULL
the	NULL
characteristic	NULL
electron-dense	NULL
structures	NULL
were	NULL
not	NULL
observed	NULL
when	NULL
the	NULL
gold-labeled	NULL
goat	NULL
anti-rabbit	NULL
IgG	NULL
alone	NULL
was	NULL
used	NULL
for	NULL
detection	NULL
.	NULL

Second	NULL
,	NULL
electron-dense	NULL
structures	NULL
detected	NULL
by	NULL
anti-LYSP100	NULL
antibodies	NULL
were	NULL
observed	NULL
frequently	NULL
in	NULL
MBBI1	NULL
cells	NULL
but	NULL
only	NULL
rarely	NULL
in	NULL
HeLa	NULL
cells	NULL
,	NULL
as	NULL
predicted	NULL
by	NULL
the	NULL
preferential	NULL
expression	NULL
of	NULL
LYSP100	NULL
in	NULL
lymphoid	NULL
cells	NULL
.	NULL

LYSP100-associated	NULL
structures	NULL
and	NULL
PML	NULL
NBs	NULL
were	NULL
morphologically	NULL
distinct	NULL
in	NULL
several	NULL
respects	NULL
.	NULL

First	NULL
,	NULL
LYSP100	NULL
structures	NULL
often	NULL
appeared	NULL
more	NULL
electron-dense	NULL
than	NULL
PML	NULL
NBs	NULL
(	NULL
Fig	NULL
9C	NULL
and	NULL
D	NULL
,	NULL
LYSP10O0	NULL
structures	NULL
marked	NULL
by	NULL
big	NULL
arrows-PML	NULL
NBs	NULL
marked	NULL
by	NULL
small	NULL
arrows	NULL
)	NULL
.	NULL

Second	NULL
,	NULL
LYSP100	NULL
was	NULL
never	NULL
detected	NULL
in	NULL
a	NULL
ring-like	NULL
electron-dense	NULL
structure	NULL
,	NULL
which	NULL
is	NULL
a	NULL
hallmark	NULL
of	NULL
PML	NULL
NBs	NULL
.	NULL
``	NULL

Third	NULL
,	NULL
the	NULL
dot-like	NULL
LYSP100	NULL
structures	NULL
were	NULL
uniformly	NULL
decorated	NULL
by	NULL
LYSP100	NULL
antibodies	NULL
(	NULL
Fig	NULL
8A	NULL
to	NULL
D	NULL
)	NULL
,	NULL
whereas	NULL
PML	NULL
tended	NULL
to	NULL
localize	NULL
over	NULL
the	NULL
outer-ring	NULL
structure	NULL
of	NULL
PML	NULL
NBs	NULL
(	NULL
Fig	NULL
9C	NULL
and	NULL
D	NULL
)	NULL
.	NULL

LYSP100	NULL
therefore	NULL
appears	NULL
to	NULL
be	NULL
associated	NULL
with	NULL
a	NULL
novel	NULL
nuclear	NULL
domain	NULL
that	NULL
is	NULL
distinct	NULL
from	NULL
PML	NULL
NBs	NULL
and	NULL
other	NULL
well-characterized	NULL
subnuclear	NULL
structures	NULL
.	NULL

We	NULL
therefore	NULL
propose	NULL
to	NULL
name	NULL
these	NULL
subnuclear	NULL
domains	NULL
``	NULL
LANDs	NULL
,	NULL
``	NULL
``	NULL
for	NULL
LYSP100-associated	NULL
nuclear	NULL
domains	NULL
.	NULL

In	NULL
sections	NULL
stained	NULL
with	NULL
both	NULL
LYSP100	NULL
and	NULL
PML	NULL
antibodies	NULL
,	NULL
most	NULL
LANDs	NULL
were	NULL
found	NULL
to	NULL
stain	NULL
only	NULL
with	NULL
LYSP100	NULL
.	NULL

Furthermore	NULL
,	NULL
most	NULL
PML	NULL
staining	NULL
was	NULL
detected	NULL
in	NULL
typical	NULL
PML	NULL
NBs	NULL
.	NULL

However	NULL
,	NULL
some	NULL
LANDs	NULL
were	NULL
decorated	NULL
with	NULL
both	NULL
10-nm	NULL
and	NULL
15-nm	NULL
gold	NULL
particles	NULL
,	NULL
indicating	NULL
the	NULL
presence	NULL
of	NULL
both	NULL
L¥SP100	NULL
and	NULL
PML	NULL
,	NULL
respectively	NULL
(	NULL
Fig	NULL
9	NULL
)	NULL
.	NULL

These	NULL
PML	NULL
and	NULL
LYSP100	NULL
costaining	NULL
structures	NULL
appeared	NULL
to	NULL
have	NULL
the	NULL
characteristics	NULL
of	NULL
LANDs	NULL
,	NULL
as	NULL
already	NULL
described	NULL
,	NULL
rather	NULL
than	NULL
the	NULL
characteristics	NULL
of	NULL
PML	NULL
NBs	NULL
.	NULL

Indeed	NULL
,	NULL
LANDs	NULL
that	NULL
contained	NULL
PML	NULL
could	NULL
not	NULL
be	NULL
readily	NULL
distinguished	NULL
by	NULL
morphology	NULL
from	NULL
those	NULL
that	NULL
did	NULL
not	NULL
.	NULL

The	NULL
ratio	NULL
of	NULL
LYSP100	NULL
to	NULL
PML	NULL
gold	NULL
particles	NULL
in	NULL
the	NULL
structures	NULL
shown	NULL
in	NULL
Fig	NULL
9	NULL
is	NULL
2.0	NULL
+	NULL
0.49	NULL
.	NULL

The	NULL
relatively	NULL
low	NULL
variation	NULL
in	NULL
this	NULL
ratio	NULL
points	NULL
to	NULL
a	NULL
consistency	NULL
in	NULL
the	NULL
molecular	NULL
composition	NULL
of	NULL
the	NULL
LANDs	NULL
to	NULL
which	NULL
both	NULL
LYSP100	NULL
and	NULL
PML	NULL
localize	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
LYSP100	NULL
,	NULL
antibodies	NULL
to	NULL
SP100	NULL
stained	NULL
characteristic	NULL
PML	NULL
NBs	NULL
exclusively	NULL
,	NULL
and	NULL
were	NULL
not	NULL
detected	NULL
in	NULL
structures	NULL
with	NULL
LAND	NULL
morphology	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

EM	NULL
provided	NULL
several	NULL
intriguing	NULL
refinements	NULL
for	NULL
the	NULL
characterization	NULL
of	NULL
subcellular	NULL
distribution	NULL
of	NULL
LANDs	NULL
.	NULL

Most	NULL
LANDs	NULL
were	NULL
observed	NULL
within	NULL
the	NULL
nucleoplasm	NULL
in	NULL
the	NULL
interchromatin	NULL
space	NULL
(	NULL
Figs	NULL
8A	NULL
and	NULL
9A	NULL
and	NULL
D	NULL
)	NULL
.	NULL

However	NULL
,	NULL
many	NULL
LANDs	NULL
were	NULL
localized	NULL
precisely	NULL
at	NULL
the	NULL
nuclear	NULL
envelope	NULL
,	NULL
sometimes	NULL
on	NULL
the	NULL
nuclear	NULL
face	NULL
(	NULL
Fig	NULL
9C	NULL
)	NULL
and	NULL
in	NULL
other	NULL
cases	NULL
on	NULL
the	NULL
cytoplasmic	NULL
face	NULL
(	NULL
Figs	NULL
8B	NULL
and	NULL
C	NULL
and	NULL
9B	NULL
)	NULL
.	NULL

Frequently	NULL
,	NULL
these	NULL
LANDs	NULL
were	NULL
seen	NULL
at	NULL
the	NULL
tip	NULL
of	NULL
deep	NULL
invaginations	NULL
of	NULL
the	NULL
nuclear	NULL
envelope	NULL
into	NULL
the	NULL
nucleus	NULL
(	NULL
Figs	NULL
8B	NULL
and	NULL
9B	NULL
)	NULL
.	NULL

Approximately	NULL
one	NULL
fifth	NULL
of	NULL
the	NULL
LANDs	NULL
were	NULL
observed	NULL
in	NULL
the	NULL
cytoplasm	NULL
and	NULL
were	NULL
morphologically	NULL
indistinguishable	NULL
from	NULL
LANDs	NULL
present	NULL
in	NULL
the	NULL
nucleoplasm	NULL
(	NULL
Fig	NULL
8D	NULL
)	NULL
.	NULL

LANDs	NULL
that	NULL
contained	NULL
PML	NULL
showed	NULL
a	NULL
similar	NULL
subcellular	NULL
distribution	NULL
compared	NULL
with	NULL
LANDs	NULL
devoid	NULL
of	NULL
PML	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
morphologically	NULL
similar	NULL
LANDs	NULL
were	NULL
observed	NULL
in	NULL
the	NULL
nucleo-	NULL
Fig	NULL
7	NULL
.	NULL

-	NULL
Laser-scanning	NULL
confocal	NULL
microscopy	NULL
of	NULL
MBBI1	NULL
cells	NULL
stained	NULL
with	NULL
anti-LYSP100	NULL
(	NULL
green	NULL
fluorescence	NULL
)	NULL
and	NULL
anti-SP100	NULL
antibodies	NULL
(	NULL
red	NULL
fluorescence	NULL
)	NULL
.	NULL

Colocalization	NULL
of	NULL
green	NULL
and	NULL
red	NULL
fluorescence	NULL
yields	NULL
a	NULL
yellow	NULL
image	NULL
.	NULL

A	NULL
,	NULL
B	NULL
,	NULL
and	NULL
C	NULL
,	NULL
3	NULL
individual	NULL
cells	NULL
representative	NULL
of	NULL
the	NULL
minority	NULL
of	NULL
cells	NULL
where	NULL
LYSP100	NULL
and	NULL
SP100	NULL
colocalized	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1432	NULL
plasm	NULL
,	NULL
at	NULL
the	NULL
nuclear	NULL
membrane	NULL
,	NULL
and	NULL
in	NULL
the	NULL
cytoplasm	NULL
,	NULL
raising	NULL
the	NULL
possibility	NULL
that	NULL
LANDs	NULL
are	NULL
transported	NULL
between	NULL
these	NULL
compartments	NULL
.	NULL

DISCUSSION	NULL
We	NULL
have	NULL
cloned	NULL
a	NULL
novel	NULL
lymphoid-restricted	NULL
nuclear	NULL
factor	NULL
,	NULL
LYSP100	NULL
,	NULL
that	NULL
is	NULL
homologous	NULL
to	NULL
SP100	NULL
,	NULL
a	NULL
protein	NULL
found	NULL
in	NULL
dot-like	NULL
nuclear	NULL
domains	NULL
termed	NULL
PML	NULL
NBs	NULL
.	NULL

As	NULL
analyzed	NULL
by	NULL
confocal	NULL
immunofluorescence	NULL
microscopy	NULL
,	NULL
LYSP	NULL
100	NULL
was	NULL
also	NULL
localized	NULL
in	NULL
dot-like	NULL
subnuclear	NULL
structures	NULL
,	NULL
but	NULL
,	NULL
surprisingly	NULL
,	NULL
LYSP100	NULL
dots	NULL
were	NULL
generally	NULL
nonoverlapping	NULL
with	NULL
PML	NULL
NBs	NULL
.	NULL

By	NULL
immuno-EM	NULL
,	NULL
LYSP100	NULL
was	NULL
found	NULL
in	NULL
novel	NULL
electron-dense	NULL
globular	NULL
structures	NULL
that	NULL
were	NULL
morphologically	NULL
distinct	NULL
from	NULL
PML	NULL
NBs	NULL
and	NULL
other	NULL
previously	NULL
described	NULL
subnuclear	NULL
structures	NULL
.	NULL

Thus	NULL
,	NULL
LYSP100	NULL
molecularly	NULL
defines	NULL
a	NULL
novel	NULL
subnuclear	NULL
domain	NULL
,	NULL
which	NULL
we	NULL
term	NULL
LAND	NULL
,	NULL
for	NULL
LYSP100-associated	NULL
nuclear	NULL
domain	NULL
.	NULL

Interestingly	NULL
,	NULL
in	NULL
a	NULL
minor	NULL
population	NULL
of	NULL
LANDs	NULL
,	NULL
LYSP100	NULL
and	NULL
PML	NULL
did	NULL
colocal-ize	NULL
,	NULL
as	NULL
judged	NULL
by	NULL
immuno-EM	NULL
.	NULL

Our	NULL
data	NULL
thus	NULL
reveal	NULL
LANDs	NULL
as	NULL
a	NULL
new	NULL
class	NULL
of	NULL
nuclear	NULL
structures	NULL
associated	NULL
with	NULL
PML	NULL
.	NULL

LYSP100	NULL
and	NULL
SP100	NULL
genes	NULL
likely	NULL
evolved	NULL
from	NULL
a	NULL
common	NULL
ancestor	NULL
,	NULL
since	NULL
they	NULL
encode	NULL
proteins	NULL
that	NULL
share	NULL
several	NULL
regions	NULL
of	NULL
homology	NULL
.	NULL

All	NULL
LYSP100	NULL
and	NULL
SP100	NULL
isoforms	NULL
share	NULL
a	NULL
highly	NULL
conserved	NULL
157-amino	NULL
acid	NULL
amino-terminal	NULL
domain	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
one	NULL
isoform	NULL
of	NULL
LYSP100	NULL
,	NULL
LYSP100-B	NULL
,	NULL
contains	NULL
a	NULL
carboxy-terminal	NULL
extension	NULL
of	NULL
470	NULL
amino	NULL
acids	NULL
that	NULL
bears	NULL
homology	NULL
with	NULL
HNPP	NULL
,	NULL
a	NULL
nuclear	NULL
phosphoprotein	NULL
that	NULL
is	NULL
strongly	NULL
induced	NULL
following	NULL
interferon	NULL
treatment	NULL
of	NULL
cells	NULL
.	NULL
``	NULL

We	NULL
used	NULL
this	NULL
LYSP10O0	NULL
isoform	NULL
to	NULL
identify	NULL
a	NULL
previously	NULL
undescribed	NULL
SP100	NULL
isoform	NULL
,	NULL
SP100-B	NULL
,	NULL
which	NULL
also	NULL
contains	NULL
a	NULL
carboxy-terminal	NULL
HNPP	NULL
domain	NULL
.	NULL

A	NULL
common	NULL
feature	NULL
of	NULL
S	NULL
$	NULL
P100	NULL
,	NULL
HNPP	NULL
,	NULL
and	NULL
PML	NULL
is	NULL
that	NULL
they	NULL
are	NULL
strongly	NULL
upregulated	NULL
by	NULL
interferon	NULL
treatment	NULL
of	NULL
cells	NULL
.	NULL

***	NULL
``	NULL
By	NULL
contrast	NULL
,	NULL
interferon	NULL
treatment	NULL
has	NULL
only	NULL
a	NULL
modest	NULL
(	NULL
~twofold	NULL
)	NULL
effect	NULL
on	NULL
LYSP100	NULL
mRNA	NULL
expression	NULL
(	NULL
A.L	NULL
.	NULL

Dent	NULL
,	NULL
unpublished	NULL
observations	NULL
,	NULL
September	NULL
1993	NULL
)	NULL
.	NULL

Of	NULL
particular	NULL
note	NULL
,	NULL
LYSP100-B	NULL
shares	NULL
two	NULL
homology	NULL
regions	NULL
with	NULL
several	NULL
transcriptional	NULL
regulatory	NULL
proteins	NULL
,	NULL
the	NULL
PHD/TTC	NULL
domain	NULL
and	NULL
the	NULL
bromodomain	NULL
.	NULL

The	NULL
PHD/TTC	NULL
domain	NULL
is	NULL
defined	NULL
by	NULL
a	NULL
characteristic	NULL
arrangement	NULL
of	NULL
cysteine	NULL
and	NULL
histidine	NULL
residues	NULL
,	NULL
C	NULL
,	NULL
HC	NULL
;	NULL
,	NULL
``	NULL
°*	NULL
and	NULL
is	NULL
a	NULL
potential	NULL
zinc-coordination	NULL
motif	NULL
.	NULL
``	NULL

Two	NULL
PHD/TTC	NULL
domain	NULL
proteins	NULL
,	NULL
CBP	NULL
and	NULL
p300	NULL
,	NULL
mediate	NULL
transcriptional	NULL
activation	NULL
through	NULL
the	NULL
cAMP-responsive	NULL
transcription	NULL
factor	NULL
,	NULL
CREB	NULL
.	NULL
``	NULL

The	NULL
PHD/	NULL
TTC	NULL
motif	NULL
is	NULL
also	NULL
repeated	NULL
four	NULL
times	NULL
in	NULL
the	NULL
Drosophila	NULL
homeotic	NULL
protein	NULL
,	NULL
trithorax	NULL
,	NULL
a	NULL
positive	NULL
regulator	NULL
of	NULL
transcription	NULL
that	NULL
is	NULL
responsible	NULL
for	NULL
maintenance	NULL
of	NULL
the	NULL
transcription	NULL
of	NULL
homeotic	NULL
selector	NULL
genes	NULL
.	NULL
``	NULL

The	NULL
MLL	NULL
gene	NULL
,	NULL
a	NULL
trithorax	NULL
homologue	NULL
translocated	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
human	NULL
leukemias	NULL
,	NULL
``	NULL
``	NULL
``	NULL
*	NULL
has	NULL
particularly	NULL
high	NULL
sequence	NULL
homology	NULL
with	NULL
trithorax	NULL
in	NULL
the	NULL
PHD/TTC	NULL
region	NULL
.	NULL

The	NULL
closest	NULL
homologue	NULL
to	NULL
LYSP100-B	NULL
in	NULL
the	NULL
PHD/TTC	NULL
domain	NULL
is	NULL
TIF1	NULL
,	NULL
a	NULL
potential	NULL
coactivator	NULL
protein	NULL
for	NULL
nuclear	NULL
hormone	NULL
receptors	NULL
.	NULL
``	NULL

TIFI	NULL
binds	NULL
to	NULL
the	NULL
AF-2	NULL
activation	NULL
domains	NULL
of	NULL
nuclear	NULL
hormone	NULL
receptors	NULL
in	NULL
a	NULL
ligand-dependent	NULL
fashion	NULL
and	NULL
can	NULL
stimulate	NULL
transcription	NULL
through	NULL
these	NULL
receptors	NULL
in	NULL
yeast	NULL
.	NULL
``	NULL

Interestingly	NULL
,	NULL
TIF-1	NULL
displays	NULL
a	NULL
more	NULL
extended	NULL
homology	NULL
with	NULL
LYSP100-B	NULL
that	NULL
includes	NULL
the	NULL
bromodomain	NULL
and	NULL
the	NULL
spacer	NULL
region	NULL
between	NULL
the	NULL
two	NULL
domains	NULL
,	NULL
suggesting	NULL
DENT	NULL
ET	NULL
AL	NULL
that	NULL
these	NULL
two	NULL
domains	NULL
perform	NULL
related	NULL
functions	NULL
in	NULL
the	NULL
two	NULL
proteins	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
TIF1	NULL
,	NULL
the	NULL
coactivator	NULL
proteins	NULL
,	NULL
CBP	NULL
and	NULL
p300	NULL
,	NULL
also	NULL
contain	NULL
both	NULL
a	NULL
bromodomain	NULL
and	NULL
a	NULL
PHD/	NULL
TTC	NULL
domain	NULL
.	NULL

The	NULL
bromodomain	NULL
is	NULL
also	NULL
found	NULL
in	NULL
CCGI1I/	NULL
hTAFH250	NULL
,	NULL
``	NULL
*°°	NULL
a	NULL
protein	NULL
that	NULL
is	NULL
tightly	NULL
associated	NULL
with	NULL
TATA	NULL
binding	NULL
factor	NULL
and	NULL
is	NULL
required	NULL
for	NULL
the	NULL
function	NULL
of	NULL
certain	NULL
transcriptional	NULL
activation	NULL
domains	NULL
.	NULL
``	NULL

A	NULL
large	NULL
,	NULL
functionally	NULL
distinct	NULL
class	NULL
of	NULL
bromodomain	NULL
proteins	NULL
are	NULL
homo-logues	NULL
of	NULL
the	NULL
Drosophila	NULL
homeotic	NULL
protein	NULL
,	NULL
Brahma	NULL
,	NULL
and	NULL
the	NULL
yeast	NULL
SWI2/SNF2	NULL
protein	NULL
,	NULL
and	NULL
appear	NULL
to	NULL
contribute	NULL
to	NULL
a	NULL
multiprotein	NULL
complex	NULL
that	NULL
disrupts	NULL
chromatin	NULL
.	NULL

``	NULL
*	NULL
Although	NULL
the	NULL
precise	NULL
function	NULL
of	NULL
the	NULL
bromodomain	NULL
is	NULL
not	NULL
yet	NULL
clear	NULL
,	NULL
deletion	NULL
of	NULL
this	NULL
domain	NULL
in	NULL
the	NULL
yeast	NULL
transcriptional	NULL
adaptor	NULL
protein	NULL
,	NULL
impairs	NULL
its	NULL
ability	NULL
to	NULL
activate	NULL
transcription	NULL
mediated	NULL
by	NULL
certain	NULL
activation	NULL
domains	NULL
.	NULL
``	NULL

These	NULL
sequence	NULL
homologies	NULL
provide	NULL
provocative	NULL
,	NULL
albeit	NULL
preliminary	NULL
,	NULL
indications	NULL
that	NULL
LYSP100	NULL
may	NULL
participate	NULL
in	NULL
transcriptional	NULL
regulation	NULL
.	NULL

The	NULL
lymphoid-restricted	NULL
expression	NULL
of	NULL
LYSP100	NULL
further	NULL
suggests	NULL
that	NULL
LYSP100	NULL
does	NULL
not	NULL
perform	NULL
a	NULL
merely	NULL
``	NULL
housekeeping	NULL
``	NULL
function	NULL
,	NULL
but	NULL
instead	NULL
may	NULL
act	NULL
to	NULL
regulate	NULL
transcription	NULL
in	NULL
a	NULL
cell	NULL
type-specific	NULL
fashion	NULL
.	NULL

LANDs	NULL
were	NULL
distinct	NULL
in	NULL
location	NULL
and	NULL
morphology	NULL
from	NULL
other	NULL
subnuclear	NULL
structures	NULL
that	NULL
have	NULL
been	NULL
molecularly	NULL
de-fined	NULL
,	NULL
including	NULL
interchromatin	NULL
granules	NULL
,	NULL
perichromatin	NULL
fibrils	NULL
,	NULL
coiled	NULL
bodies	NULL
,	NULL
and	NULL
PML	NULL
NBs	NULL
.	NULL

EM	NULL
showed	NULL
LANDs	NULL
to	NULL
be	NULL
round	NULL
or	NULL
irregularly	NULL
shaped	NULL
electron-dense	NULL
structures	NULL
ranging	NULL
in	NULL
size	NULL
from	NULL
0.1	NULL
to	NULL
0.3	NULL
wm	NULL
.	NULL

Three-dimensional	NULL
confocal	NULL
image	NULL
plane	NULL
reconstruction	NULL
of	NULL
LANDs	NULL
showed	NULL
them	NULL
to	NULL
be	NULL
solid	NULL
,	NULL
roughly	NULL
spherical	NULL
structures	NULL
(	NULL
A.L.D	NULL
.	NULL

,	NULL
J.	NULL
Y.	NULL
,	NULL
and	NULL
L.M.S	NULL
.	NULL

,	NULL
unpublished	NULL
data	NULL
,	NULL
March	NULL
1994	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
morphology	NULL
of	NULL
LANDs	NULL
as	NULL
revealed	NULL
by	NULL
immunofluorescence	NULL
or	NULL
EM	NULL
is	NULL
not	NULL
notably	NULL
distinctive	NULL
,	NULL
and	NULL
consequently	NULL
,	NULL
this	NULL
novel	NULL
nuclear	NULL
sub-domain	NULL
could	NULL
not	NULL
have	NULL
been	NULL
appreciated	NULL
without	NULL
the	NULL
cloning	NULL
and	NULL
characterization	NULL
of	NULL
LYSP1OO0	NULL
.	NULL

At	NULL
present	NULL
,	NULL
since	NULL
LYSP100	NULL
is	NULL
a	NULL
lymphoid-restricted	NULL
protein	NULL
,	NULL
it	NULL
is	NULL
not	NULL
possible	NULL
to	NULL
convincingly	NULL
demonstrate	NULL
that	NULL
LANDs	NULL
exist	NULL
in	NULL
nonlymphoid	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
in	NULL
this	NULL
regard	NULL
,	NULL
it	NULL
is	NULL
noteworthy	NULL
that	NULL
when	NULL
LYSP100-B	NULL
was	NULL
expressed	NULL
in	NULL
HeLa	NULL
cells	NULL
by	NULL
transfection	NULL
,	NULL
LYSP100	NULL
antibodies	NULL
detected	NULL
dot-like	NULL
nuclear	NULL
structures	NULL
by	NULL
immunofluorescence	NULL
that	NULL
were	NULL
indistinguishable	NULL
from	NULL
LANDs	NULL
detected	NULL
in	NULL
lymphoid	NULL
cells	NULL
.	NULL

One	NULL
interpretation	NULL
of	NULL
this	NULL
result	NULL
is	NULL
that	NULL
the	NULL
ectopically	NULL
expressed	NULL
LYSP100	NULL
was	NULL
incorporated	NULL
into	NULL
LAND-like	NULL
structures	NULL
that	NULL
preexisted	NULL
in	NULL
HeLa	NULL
cells	NULL
Alternatively	NULL
but	NULL
seemingly	NULL
less	NULL
likely	NULL
,	NULL
LYSP100	NULL
might	NULL
organize	NULL
de	NULL
novo	NULL
LANDs	NULL
within	NULL
HeLa	NULL
cells	NULL
.	NULL

The	NULL
ultrastructural	NULL
location	NULL
of	NULL
LANDs	NULL
may	NULL
provide	NULL
some	NULL
intimation	NULL
of	NULL
their	NULL
function	NULL
.	NULL

The	NULL
greatest	NULL
number	NULL
of	NULL
LANDs	NULL
was	NULL
observed	NULL
in	NULL
the	NULL
nucleoplasm	NULL
,	NULL
where	NULL
they	NULL
could	NULL
be	NULL
detected	NULL
in	NULL
the	NULL
interchromatin	NULL
regions	NULL
(	NULL
Figs	NULL
7	NULL
and	NULL
8	NULL
)	NULL
and	NULL
in	NULL
the	NULL
nucleolar	NULL
regions	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

However	NULL
,	NULL
in	NULL
addition	NULL
,	NULL
many	NULL
LANDs	NULL
were	NULL
directly	NULL
touching	NULL
the	NULL
nuclear	NULL
envelope	NULL
,	NULL
both	NULL
on	NULL
the	NULL
nuclear	NULL
and	NULL
cytoplasmic	NULL
face	NULL
,	NULL
and	NULL
approximately	NULL
one	NULL
fifth	NULL
of	NULL
the	NULL
LANDs	NULL
were	NULL
in	NULL
the	NULL
cytoplasm	NULL
proper	NULL
.	NULL

In-triguingly	NULL
,	NULL
LANDs	NULL
were	NULL
frequently	NULL
observed	NULL
at	NULL
the	NULL
tip	NULL
of	NULL
deep	NULL
invaginations	NULL
of	NULL
the	NULL
nuclear	NULL
membrane	NULL
(	NULL
Figs	NULL
7B	NULL
and	NULL
8B	NULL
)	NULL
.	NULL

It	NULL
is	NULL
unclear	NULL
how	NULL
such	NULL
invaginations	NULL
in	NULL
the	NULL
nuclear	NULL
envelope	NULL
are	NULL
formed	NULL
and	NULL
maintained	NULL
,	NULL
but	NULL
they	NULL
could	NULL
conceivably	NULL
represent	NULL
functional	NULL
specializations	NULL
of	NULL
the	NULL
nuclear	NULL
enve-	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

NOVEL	NULL
NUCLEAR	NULL
STRUCTURES	NULL
DEFINED	NULL
BY	NULL
LYSP100	NULL
F	NULL
|	NULL
A|	NULL
pee	NULL
Fig	NULL
8	NULL
.	NULL

-	NULL
Immuno-EM	NULL
of	NULL
MBB1	NULL
lymphoblastoid	NULL
cells	NULL
stained	NULL
with	NULL
anti-LYSP100	NULL
antibodies	NULL
.	NULL

LANDs	NULL
were	NULL
detected	NULL
in	NULL
the	NULL
nucleoplasm	NULL
(	NULL
A	NULL
)	NULL
,	NULL
at	NULL
the	NULL
nuclear	NULL
envelope	NULL
(	NULL
B	NULL
and	NULL
C	NULL
)	NULL
,	NULL
and	NULL
in	NULL
the	NULL
cytoplasm	NULL
(	NULL
D	NULL
)	NULL
.	NULL

Nu	NULL
,	NULL
nucleolus	NULL
;	NULL
NE	NULL
,	NULL
nuclear	NULL
envelope	NULL
;	NULL
M	NULL
,	NULL
mitochondrion	NULL
.	NULL

Original	NULL
magnification	NULL
:	NULL
A	NULL
,	NULL
x	NULL
66,000	NULL
;	NULL
B	NULL
to	NULL
D	NULL
,	NULL
x	NULL
39,000.	NULL
lope	NULL
.	NULL

These	NULL
observations	NULL
suggest	NULL
the	NULL
possibility	NULL
that	NULL
LANDs	NULL
may	NULL
traverse	NULL
the	NULL
nucleus	NULL
to	NULL
the	NULL
cytoplasm	NULL
,	NULL
or	NULL
vice	NULL
versa	NULL
.	NULL

In	NULL
the	NULL
former	NULL
case	NULL
,	NULL
LANDs	NULL
might	NULL
be	NULL
multisubunit	NULL
structures	NULL
that	NULL
,	NULL
like	NULL
ribosomes	NULL
,	NULL
are	NULL
assembled	NULL
in	NULL
the	NULL
nucleus	NULL
but	NULL
function	NULL
in	NULL
the	NULL
cytoplasm	NULL
.	NULL

Alternatively	NULL
,	NULL
LANDs	NULL
might	NULL
be	NULL
directly	NULL
involved	NULL
in	NULL
the	NULL
transport	NULL
of	NULL
macromolecules	NULL
such	NULL
as	NULL
RNA	NULL
from	NULL
the	NULL
nucleus	NULL
to	NULL
the	NULL
cytoplasm	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
LANDs	NULL
,	NULL
like	NULL
snRNPs	NULL
,	NULL
``	NULL
°	NULL
may	NULL
be	NULL
assembled	NULL
in	NULL
the	NULL
cytoplasm	NULL
and	NULL
then	NULL
imported	NULL
into	NULL
the	NULL
nucleus	NULL
.	NULL

Once	NULL
in	NULL
the	NULL
nucleus	NULL
,	NULL
LANDs	NULL
may	NULL
serve	NULL
as	NULL
sites	NULL
where	NULL
specialized	NULL
nuclear	NULL
functions	NULL
take	NULL
place	NULL
,	NULL
or	NULL
they	NULL
may	NULL
be	NULL
storage	NULL
areas	NULL
for	NULL
proteins	NULL
that	NULL
can	NULL
be	NULL
released	NULL
from	NULL
LANDs	NULL
to	NULL
function	NULL
elsewhere	NULL
in	NULL
the	NULL
nucleus	NULL
.	NULL

Finally	NULL
,	NULL
our	NULL
data	NULL
provide	NULL
evidence	NULL
for	NULL
the	NULL
association	NULL
of	NULL
PML	NULL
with	NULL
a	NULL
subnuclear	NULL
structure	NULL
other	NULL
than	NULL
the	NULL
PML	NULL
NB	NULL
.	NULL

PML-containing	NULL
LANDs	NULL
were	NULL
found	NULL
in	NULL
the	NULL
nucleoplasm	NULL
,	NULL
at	NULL
the	NULL
nuclear	NULL
membrane	NULL
,	NULL
and	NULL
in	NULL
the	NULL
cytoplasm	NULL
,	NULL
and	NULL
were	NULL
morphologically	NULL
indistinguishable	NULL
from	NULL
LANDs	NULL
lacking	NULL
PML	NULL
.	NULL

Previously	NULL
,	NULL
PML	NULL
has	NULL
been	NULL
localized	NULL
by	NULL
immunofluorescence	NULL
to	NULL
the	NULL
cytoplasm	NULL
of	NULL
some	NULL
cells	NULL
,	NULL
``	NULL
yet	NULL
PML	NULL
NBs	NULL
have	NULL
only	NULL
been	NULL
described	NULL
by	NULL
EM	NULL
in	NULL
the	NULL
nucleo-plasm	NULL
.	NULL

Therefore	NULL
,	NULL
some	NULL
of	NULL
the	NULL
previously	NULL
described	NULL
cytoplasmic	NULL
PML	NULL
may	NULL
be	NULL
attributable	NULL
to	NULL
LANDs	NULL
.	NULL

Furthermore	NULL
,	NULL
although	NULL
the	NULL
majority	NULL
of	NULL
PML	NULL
in	NULL
the	NULL
nucleus	NULL
is	NULL
associated	NULL
with	NULL
PML	NULL
NBs	NULL
,	NULL
some	NULL
of	NULL
the	NULL
nuclear	NULL
dots	NULL
detected	NULL
by	NULL
immunofluorescence	NULL
with	NULL
anti-PML	NULL
antibodies	NULL
could	NULL
represent	NULL
LANDs	NULL
.	NULL

Recent	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
PML	NULL
can	NULL
suppress	NULL
the	NULL
growth	NULL
and	NULL
malignant	NULL
transformation	NULL
of	NULL
cells	NULL
,	NULL
``	NULL
``	NULL
and	NULL
can	NULL
repress	NULL
the	NULL
activity	NULL
of	NULL
certain	NULL
promoters	NULL
in	NULL
transient	NULL
transfection	NULL
assays	NULL
.	NULL
``	NULL

The	NULL
present	NULL
results	NULL
suggest	NULL
that	NULL
LANDs	NULL
should	NULL
be	NULL
taken	NULL
into	NULL
consideration	NULL
in	NULL
models	NULL
of	NULL
PML	NULL
function	NULL
.	NULL

One	NULL
possibility	NULL
raised	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
PML	NULL
in	NULL
both	NULL
LANDs	NULL
and	NULL
PML	NULL
NBs	NULL
is	NULL
that	NULL
LANDs	NULL
might	NULL
be	NULL
precursors	NULL
in	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1434	NULL
DENT	NULL
ET	NULL
AL	NULL
Lad	NULL
Fig	NULL
9	NULL
.	NULL

Simultaneous	NULL
visualization	NULL
of	NULL
LYSP100	NULL
and	NULL
PML	NULL
in	NULL
MBB1	NULL
lymphoblastoid	NULL
cells	NULL
by	NULL
immuno-EM	NULL
.	NULL

Anti-LYSP100	NULL
antibodies	NULL
were	NULL
detected	NULL
with	NULL
antibodies	NULL
coupled	NULL
with	NULL
10-nm	NULL
gold	NULL
particles	NULL
,	NULL
and	NULL
anti-PML	NULL
antibodies	NULL
with	NULL
antibodies	NULL
coupled	NULL
with	NULL
15-nm	NULL
gold	NULL
particles	NULL
.	NULL

LANDs	NULL
containing	NULL
both	NULL
LYSP100	NULL
and	NULL
PML	NULL
were	NULL
detected	NULL
in	NULL
the	NULL
nucleoplasm	NULL
(	NULL
A	NULL
and	NULL
D	NULL
)	NULL
and	NULL
at	NULL
the	NULL
nuclear	NULL
envelope	NULL
(	NULL
B	NULL
and	NULL
C	NULL
)	NULL
.	NULL

C	NULL
and	NULL
D	NULL
,	NULL
large	NULL
arrows	NULL
point	NULL
to	NULL
LANDs	NULL
and	NULL
small	NULL
arrows	NULL
to	NULL
PML	NULL
NB	NULL
structures	NULL
stained	NULL
only	NULL
with	NULL
anti-PML	NULL
antibodies	NULL
.	NULL

Nu	NULL
,	NULL
nucleolus	NULL
;	NULL
NE	NULL
,	NULL
nuclear	NULL
envelope	NULL
.	NULL

Original	NULL
magnification	NULL
:	NULL
A	NULL
,	NULL
B	NULL
,	NULL
and	NULL
D	NULL
,	NULL
x	NULL
51,000	NULL
;	NULL
C	NULL
,	NULL
x	NULL
42,000.	NULL
the	NULL
biogenesis	NULL
of	NULL
PML	NULL
NBs	NULL
.	NULL

Conceivably	NULL
,	NULL
PML-containing	NULL
LANDs	NULL
might	NULL
coalesce	NULL
to	NULL
generate	NULL
the	NULL
ring-like	NULL
PML	NULL
NBs	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
the	NULL
confocal	NULL
immunofluorescence	NULL
image	NULL
of	NULL
LYSP100	NULL
surrounded	NULL
by	NULL
a	NULL
ring	NULL
of	NULL
PML	NULL
(	NULL
Fig	NULL
41	NULL
)	NULL
is	NULL
especially	NULL
intriguing	NULL
.	NULL

Given	NULL
the	NULL
annular	NULL
nature	NULL
of	NULL
PML	NULL
NBs	NULL
by	NULL
EM	NULL
,	NULL
it	NULL
seems	NULL
possible	NULL
that	NULL
the	NULL
ring-like	NULL
structures	NULL
in	NULL
Fig	NULL
41	NULL
are	NULL
unusually	NULL
large	NULL
PML	NULL
NBs	NULL
.	NULL

Thus	NULL
,	NULL
in	NULL
a	NULL
small	NULL
percentage	NULL
(	NULL
<	NULL
5	NULL
%	NULL
)	NULL
of	NULL
cells	NULL
,	NULL
LYSP100	NULL
may	NULL
be	NULL
located	NULL
in	NULL
PML	NULL
NBs	NULL
.	NULL

By	NULL
immuno-EM	NULL
,	NULL
we	NULL
were	NULL
unable	NULL
to	NULL
detect	NULL
LYSP	NULL
100	NULL
in	NULL
characteristic	NULL
PML	NULL
NBs	NULL
,	NULL
but	NULL
this	NULL
failure	NULL
may	NULL
simply	NULL
reflect	NULL
the	NULL
difficulty	NULL
of	NULL
detecting	NULL
rare	NULL
events	NULL
by	NULL
EM	NULL
.	NULL

If	NULL
LYSP100	NULL
is	NULL
indeed	NULL
present	NULL
in	NULL
a	NULL
small	NULL
subpopulation	NULL
of	NULL
PML	NULL
NBs	NULL
,	NULL
it	NULL
seems	NULL
possible	NULL
that	NULL
LANDs	NULL
are	NULL
precursors	NULL
to	NULL
these	NULL
structures	NULL
.	NULL

ACKNOWLEDGMENT	NULL
We	NULL
thank	NULL
Drs	NULL
T.	NULL
Selvaggi	NULL
and	NULL
W.	NULL
Strober	NULL
for	NULL
providing	NULL
purified	NULL
human	NULL
peripheral	NULL
blood	NULL
B	NULL
lymphocytes	NULL
,	NULL
and	NULL
J.	NULL
Powell	NULL
for	NULL
assisting	NULL
with	NULL
Fig	NULL
2	NULL
.	NULL

The	NULL
5E10	NULL
anti-PML	NULL
monoclonal	NULL
antibody	NULL
was	NULL
kindly	NULL
provided	NULL
by	NULL
Drs	NULL
L.	NULL
De	NULL
Jong	NULL
and	NULL
R.	NULL
Van	NULL
Driel	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
T.	NULL
Tran	NULL
for	NULL
expert	NULL
technical	NULL
assistance	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Spector	NULL
DL	NULL
:	NULL
Macromolecular	NULL
domains	NULL
within	NULL
the	NULL
cell	NULL
nucleus	NULL
.	NULL

Annu	NULL
Rev	NULL
Cell	NULL
Biol	NULL
9:265	NULL
,	NULL
1993	NULL
2	NULL
.	NULL

Koken	NULL
MHM	NULL
,	NULL
Puvion-Dutilleu	NULL
F.	NULL
Guillermin	NULL
MC	NULL
,	NULL
Viron	NULL
A	NULL
,	NULL
Linares-Cruz	NULL
G	NULL
,	NULL
Stuurman	NULL
N	NULL
,	NULL
de	NULL
Jong	NULL
L	NULL
,	NULL
Szostecki	NULL
C	NULL
,	NULL
Calvo	NULL
F	NULL
,	NULL
Chomienne	NULL
C	NULL
,	NULL
Degos	NULL
L	NULL
,	NULL
Puvion	NULL
E	NULL
,	NULL
de	NULL
The	NULL
H	NULL
:	NULL
The	NULL
t	NULL
(	NULL
15	NULL
;	NULL
17	NULL
)	NULL
translocation	NULL
alters	NULL
a	NULL
nuclear	NULL
body	NULL
in	NULL
a	NULL
retinoic	NULL
acid-reversible	NULL
fashion	NULL
.	NULL

EMBO	NULL
J	NULL
13:1073	NULL
,	NULL
1994	NULL
3	NULL
.	NULL

Weis	NULL
K	NULL
,	NULL
Rambaud	NULL
S	NULL
,	NULL
Lavau	NULL
C	NULL
,	NULL
Jansen	NULL
J	NULL
,	NULL
Carvalho	NULL
T	NULL
,	NULL
Carmo-Fonseca	NULL
M	NULL
,	NULL
Lamond	NULL
A	NULL
,	NULL
Dejean	NULL
A	NULL
:	NULL
Retinoic	NULL
acid	NULL
regulates	NULL
aberrant	NULL
nuclear	NULL
localization	NULL
of	NULL
PML-RARa	NULL
in	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
cells	NULL
.	NULL

Cell	NULL
76:345	NULL
,	NULL
1994	NULL
4	NULL
.	NULL

Dyck	NULL
JA	NULL
,	NULL
Maul	NULL
GG	NULL
,	NULL
Miller	NULL
WHJ	NULL
,	NULL
Chen	NULL
JD	NULL
,	NULL
Kakizuka	NULL
A	NULL
,	NULL
Evans	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

NOVEL	NULL
NUCLEAR	NULL
STRUCTURES	NULL
DEFINED	NULL
BY	NULL
LYSP100	NULL
RM	NULL
:	NULL
A	NULL
novel	NULL
macromolecular	NULL
structure	NULL
is	NULL
a	NULL
target	NULL
of	NULL
the	NULL
promyelo-cytic-retinoic	NULL
acid	NULL
receptor	NULL
oncoprotein	NULL
.	NULL

Cell	NULL
76:333	NULL
,	NULL
1994	NULL
5	NULL
.	NULL

Ascoli	NULL
C	NULL
,	NULL
Maul	NULL
G	NULL
:	NULL
Identification	NULL
of	NULL
a	NULL
novel	NULL
nuclear	NULL
domain	NULL
.	NULL

I	NULL
Cell	NULL
Biol	NULL
112:785	NULL
,	NULL
1991	NULL
6	NULL
.	NULL

Lamond	NULL
A	NULL
,	NULL
Carmo-Fonseca	NULL
M	NULL
:	NULL
The	NULL
coiled	NULL
body	NULL
.	NULL

Trends	NULL
Cell	NULL
Biol	NULL
3:198	NULL
,	NULL
1993	NULL
7	NULL
.	NULL

Daniel	NULL
MT	NULL
,	NULL
Koken	NULL
M	NULL
,	NULL
Romagne	NULL
O	NULL
,	NULL
Barbey	NULL
S	NULL
,	NULL
Bazarbachi	NULL
A	NULL
,	NULL
Stadler	NULL
M	NULL
,	NULL
Guillemin	NULL
MC	NULL
,	NULL
Degos	NULL
L	NULL
,	NULL
Chomienne	NULL
C	NULL
,	NULL
de	NULL
Thé	NULL
H	NULL
:	NULL
PML	NULL
protein	NULL
expression	NULL
in	NULL
hematopoietic	NULL
and	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
cells	NULL
.	NULL

Blood	NULL
82:1858	NULL
,	NULL
1993	NULL
8.	NULL
de	NULL
Thé	NULL
H	NULL
,	NULL
Lavau	NULL
C	NULL
,	NULL
Marchio	NULL
A	NULL
,	NULL
Chomienne	NULL
C	NULL
,	NULL
Degos	NULL
L	NULL
,	NULL
Dejean	NULL
A	NULL
:	NULL
The	NULL
PML-RARa	NULL
fusion	NULL
mRNA	NULL
generated	NULL
by	NULL
the	NULL
t	NULL
(	NULL
15	NULL
;	NULL
17	NULL
)	NULL
translocation	NULL
in	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
encodes	NULL
a	NULL
functionally	NULL
altered	NULL
RAR	NULL
.	NULL

Cell	NULL
66:675	NULL
,	NULL
1991	NULL
9	NULL
.	NULL

Goddard	NULL
AD	NULL
,	NULL
Borrow	NULL
J	NULL
,	NULL
Freemont	NULL
PS	NULL
,	NULL
Solomon	NULL
E	NULL
:	NULL
Characterization	NULL
of	NULL
a	NULL
zinc	NULL
finger	NULL
gene	NULL
disrupted	NULL
by	NULL
the	NULL
t	NULL
(	NULL
15	NULL
;	NULL
17	NULL
)	NULL
in	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
.	NULL

Science	NULL
254:1371	NULL
,	NULL
1991	NULL
10	NULL
.	NULL

Kastner	NULL
P	NULL
,	NULL
Perez	NULL
A	NULL
,	NULL
Lutz	NULL
Y	NULL
,	NULL
Rochette-Egly	NULL
C	NULL
,	NULL
Gaub	NULL
M-P	NULL
,	NULL
Durand	NULL
B	NULL
,	NULL
Lanotte	NULL
M	NULL
,	NULL
Berger	NULL
R	NULL
,	NULL
Chambon	NULL
P	NULL
:	NULL
Structure	NULL
,	NULL
localization	NULL
and	NULL
transcriptional	NULL
properties	NULL
of	NULL
two	NULL
classes	NULL
of	NULL
retinoic	NULL
acid	NULL
receptor	NULL
a	NULL
fusion	NULL
proteins	NULL
in	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
(	NULL
APL	NULL
)	NULL
:	NULL
Structural	NULL
similarities	NULL
with	NULL
a	NULL
new	NULL
family	NULL
of	NULL
oncoproteins	NULL
.	NULL

EMBO	NULL
J	NULL
11:629	NULL
,	NULL
1992	NULL
11	NULL
.	NULL

Kakizuka	NULL
A	NULL
,	NULL
Miller	NULL
WHJ	NULL
,	NULL
Umesono	NULL
K	NULL
,	NULL
Warrell	NULL
RPJ	NULL
,	NULL
Frankel	NULL
SR	NULL
,	NULL
Murty	NULL
VVVS	NULL
,	NULL
Dmitrovsky	NULL
E	NULL
,	NULL
Evans	NULL
RM	NULL
:	NULL
Chromosomal	NULL
translocation	NULL
t	NULL
(	NULL
15	NULL
;	NULL
17	NULL
)	NULL
in	NULL
human	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
fuses	NULL
RARa	NULL
with	NULL
a	NULL
novel	NULL
putative	NULL
transcription	NULL
factor	NULL
,	NULL
PML	NULL
.	NULL

Cell	NULL
66:663	NULL
,	NULL
1991	NULL
12	NULL
.	NULL

Pandolfi	NULL
PP	NULL
,	NULL
Grignani	NULL
F	NULL
,	NULL
Alcalay	NULL
M	NULL
,	NULL
Mencarelli	NULL
A	NULL
,	NULL
Biondi	NULL
A	NULL
,	NULL
LaCoco	NULL
F	NULL
,	NULL
Grignani	NULL
F	NULL
,	NULL
Pelicci	NULL
PG	NULL
:	NULL
Structure	NULL
and	NULL
origin	NULL
of	NULL
the	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
myl/RARa	NULL
cDNA	NULL
and	NULL
characterization	NULL
of	NULL
its	NULL
retinoid-binding	NULL
and	NULL
transactivation	NULL
properties	NULL
.	NULL

Oncogene	NULL
6:1285	NULL
,	NULL
1991	NULL
13	NULL
.	NULL

Stuurman	NULL
N	NULL
,	NULL
de	NULL
Graaf	NULL
A	NULL
,	NULL
Floore	NULL
A	NULL
,	NULL
Josso	NULL
A	NULL
,	NULL
Humbel	NULL
B	NULL
,	NULL
De	NULL
Jong	NULL
L	NULL
,	NULL
van	NULL
Driel	NULL
R	NULL
:	NULL
A	NULL
monoclonal	NULL
antibody	NULL
recognizing	NULL
nuclear	NULL
matrix-associated	NULL
nuclear	NULL
bodies	NULL
.	NULL

J	NULL
Cell	NULL
Sci	NULL
101:773	NULL
,	NULL
1992	NULL
14	NULL
.	NULL

Flenghi	NULL
L	NULL
,	NULL
Fagioli	NULL
M	NULL
,	NULL
Tomassoni	NULL
L	NULL
,	NULL
Pileri	NULL
S	NULL
,	NULL
Gambocorta	NULL
M	NULL
,	NULL
Pacini	NULL
R	NULL
,	NULL
Grignani	NULL
F	NULL
,	NULL
Casini	NULL
T	NULL
,	NULL
Ferrucci	NULL
PF	NULL
,	NULL
Martelli	NULL
MF	NULL
,	NULL
Pelicci	NULL
P-G	NULL
,	NULL
Falini	NULL
B	NULL
:	NULL
Characterization	NULL
of	NULL
a	NULL
new	NULL
monoclonal	NULL
antibody	NULL
(	NULL
PG-M3	NULL
)	NULL
directed	NULL
against	NULL
the	NULL
aminoterminal	NULL
portion	NULL
of	NULL
the	NULL
PML	NULL
gene	NULL
product	NULL
:	NULL
Immunocytochemical	NULL
evidence	NULL
for	NULL
high	NULL
expression	NULL
of	NULL
PML	NULL
proteins	NULL
on	NULL
activated	NULL
macrophages	NULL
,	NULL
endothelial	NULL
cells	NULL
,	NULL
and	NULL
epithelia	NULL
.	NULL

Blood	NULL
85:1871	NULL
,	NULL
1995	NULL
15	NULL
.	NULL

Terris	NULL
B	NULL
,	NULL
Baldin	NULL
V	NULL
,	NULL
Dubois	NULL
S	NULL
,	NULL
Degott	NULL
C	NULL
,	NULL
Flejou	NULL
J-F	NULL
,	NULL
Henin	NULL
D	NULL
,	NULL
Dejean	NULL
A	NULL
:	NULL
PML	NULL
nuclear	NULL
bodies	NULL
are	NULL
general	NULL
targets	NULL
of	NULL
inflammation	NULL
and	NULL
cell	NULL
proliferation	NULL
.	NULL

Cancer	NULL
Res	NULL
55:1590	NULL
,	NULL
1995	NULL
16	NULL
.	NULL

Brasch	NULL
K	NULL
,	NULL
Ochs	NULL
RL	NULL
:	NULL
Nuclear	NULL
bodies	NULL
(	NULL
NBs	NULL
)	NULL
:	NULL
A	NULL
newly	NULL
``	NULL
redis-covered	NULL
``	NULL
organelle	NULL
.	NULL

Exp	NULL
Cell	NULL
Res	NULL
202:211	NULL
,	NULL
1992	NULL
17	NULL
.	NULL

Everett	NULL
RD	NULL
,	NULL
Maul	NULL
GG	NULL
:	NULL
HSV-1	NULL
IE	NULL
protein	NULL
Vmw110	NULL
causes	NULL
redistribution	NULL
of	NULL
PML	NULL
.	NULL

EMBO	NULL
J	NULL
13:5062	NULL
,	NULL
1994	NULL
18	NULL
.	NULL

Puvion-Dutilleul	NULL
F	NULL
,	NULL
Chelbi-Alix	NULL
MK	NULL
,	NULL
Koken	NULL
M	NULL
,	NULL
Quignon	NULL
F	NULL
,	NULL
Puvion	NULL
E	NULL
,	NULL
de	NULL
Thé	NULL
H	NULL
:	NULL
Adenovirus	NULL
infection	NULL
induces	NULL
rearrangements	NULL
in	NULL
the	NULL
intranuclear	NULL
distribution	NULL
of	NULL
the	NULL
nuclear	NULL
body-associated	NULL
PML	NULL
protein	NULL
.	NULL

Exp	NULL
Cell	NULL
Res	NULL
218:9	NULL
,	NULL
1995	NULL
19	NULL
.	NULL

Alcalay	NULL
M	NULL
,	NULL
Zangrilli	NULL
D	NULL
,	NULL
Pandolfi	NULL
PP	NULL
,	NULL
Longo	NULL
L	NULL
,	NULL
Mencarelli	NULL
A	NULL
,	NULL
Giocomucci	NULL
A	NULL
,	NULL
Rocchi	NULL
M	NULL
,	NULL
Biondi	NULL
A	NULL
,	NULL
Rambaldi	NULL
A	NULL
,	NULL
Lo	NULL
Coco	NULL
F	NULL
,	NULL
Diverio	NULL
D	NULL
,	NULL
Donti	NULL
E	NULL
,	NULL
Grignani	NULL
F	NULL
,	NULL
Pelicci	NULL
PG	NULL
:	NULL
Translocation	NULL
breakpoint	NULL
of	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
lies	NULL
within	NULL
the	NULL
retinoic	NULL
acid	NULL
receptor	NULL
a	NULL
locus	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
88:1977	NULL
,	NULL
1991	NULL
20	NULL
.	NULL

Borrow	NULL
JB	NULL
:	NULL
Molecular	NULL
analysis	NULL
of	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
breakpoint	NULL
cluster	NULL
region	NULL
on	NULL
chromosome	NULL
17	NULL
.	NULL

Science	NULL
249:1577	NULL
,	NULL
1990	NULL
21.	NULL
de	NULL
The	NULL
H	NULL
,	NULL
Chomienne	NULL
C	NULL
,	NULL
Lanotte	NULL
M	NULL
,	NULL
Degos	NULL
L	NULL
,	NULL
Dejean	NULL
A	NULL
:	NULL
The	NULL
t	NULL
(	NULL
15	NULL
;	NULL
17	NULL
)	NULL
translocation	NULL
of	NULL
acute	NULL
promyelocytic	NULL
leukaemia	NULL
fuses	NULL
the	NULL
retinoic	NULL
acid	NULL
receptor	NULL
a	NULL
gene	NULL
to	NULL
a	NULL
novel	NULL
transcribed	NULL
locus	NULL
.	NULL

Nature	NULL
347:558	NULL
,	NULL
1990	NULL
1435	NULL
22	NULL
.	NULL

Grignani	NULL
F	NULL
,	NULL
Fagioli	NULL
M	NULL
,	NULL
Alcalay	NULL
M	NULL
,	NULL
Longo	NULL
L	NULL
,	NULL
Pandolfi	NULL
PP	NULL
,	NULL
Donti	NULL
E	NULL
,	NULL
Biondi	NULL
A	NULL
,	NULL
Lo	NULL
Coco	NULL
F	NULL
,	NULL
Grignani	NULL
F	NULL
,	NULL
Pelicci	NULL
PG	NULL
:	NULL
Acute	NULL
promyelocytic	NULL
leukemia	NULL
:	NULL
From	NULL
genetics	NULL
to	NULL
treatment	NULL
.	NULL

Blood	NULL
83:10	NULL
,	NULL
1994	NULL
23	NULL
.	NULL

Mu	NULL
A-M	NULL
,	NULL
Chin	NULL
K-V	NULL
,	NULL
Liu	NULL
J-H	NULL
,	NULL
Lozano	NULL
G	NULL
,	NULL
Chang	NULL
K-S	NULL
:	NULL
PML	NULL
,	NULL
a	NULL
growth	NULL
suppressor	NULL
disrupted	NULL
in	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
14:6858	NULL
,	NULL
1994	NULL
24	NULL
.	NULL

Liu	NULL
J-H	NULL
,	NULL
Mu	NULL
Z-M	NULL
,	NULL
Chang	NULL
K-S	NULL
:	NULL
PML	NULL
suppresses	NULL
oncogenic	NULL
transformation	NULL
of	NULL
NIH/3T3	NULL
cells	NULL
by	NULL
activated	NULL
neu	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
181:1965	NULL
,	NULL
1995	NULL
25	NULL
.	NULL

Koken	NULL
M	NULL
,	NULL
Linares-Cruz	NULL
G	NULL
,	NULL
Quignon	NULL
F	NULL
,	NULL
Viron	NULL
A	NULL
,	NULL
Chelbi-Alix	NULL
MK	NULL
,	NULL
Sobczak-Thépot	NULL
J	NULL
,	NULL
Juhlin	NULL
L	NULL
,	NULL
Degos	NULL
L	NULL
,	NULL
Calvo	NULL
F	NULL
,	NULL
de	NULL
Thé	NULL
H	NULL
:	NULL
The	NULL
PML	NULL
growth-suppressor	NULL
has	NULL
an	NULL
altered	NULL
expression	NULL
in	NULL
human	NULL
oncogenesis	NULL
.	NULL

Oncogene	NULL
10:1315	NULL
,	NULL
1995	NULL
26	NULL
.	NULL

Szostecki	NULL
C	NULL
,	NULL
Guldner	NULL
HH	NULL
,	NULL
Netter	NULL
HJ	NULL
,	NULL
Will	NULL
H	NULL
:	NULL
Isolation	NULL
and	NULL
characterization	NULL
of	NULL
cDNA	NULL
encoding	NULL
a	NULL
human	NULL
nuclear	NULL
antigen	NULL
predominantly	NULL
recognized	NULL
by	NULL
autoantibodies	NULL
from	NULL
patients	NULL
with	NULL
primary	NULL
biliary	NULL
cirrhosis	NULL
.	NULL

J	NULL
Immunol	NULL
145:4338	NULL
,	NULL
1990	NULL
27	NULL
.	NULL

Szostecki	NULL
K	NULL
,	NULL
Krippner	NULL
H	NULL
,	NULL
Penner	NULL
E	NULL
,	NULL
Bautz	NULL
FA	NULL
:	NULL
Autoimmune	NULL
sera	NULL
recognize	NULL
a	NULL
100	NULL
kD	NULL
nuclear	NULL
protein	NULL
antigen	NULL
(	NULL
sp-100	NULL
)	NULL
.	NULL

Clin	NULL
Exp	NULL
Immunol	NULL
68:108	NULL
,	NULL
1987	NULL
28	NULL
.	NULL

Fusconi	NULL
M	NULL
,	NULL
Cassani	NULL
F	NULL
,	NULL
Govoni	NULL
M	NULL
,	NULL
Caselli	NULL
A	NULL
,	NULL
Farabegoli	NULL
F	NULL
,	NULL
Lenzi	NULL
M	NULL
,	NULL
Ballardini	NULL
G	NULL
,	NULL
Zauli	NULL
D	NULL
,	NULL
Bianchi	NULL
FB	NULL
:	NULL
Anti-nuclear	NULL
antibodies	NULL
of	NULL
primary	NULL
biliary	NULL
cirrhosis	NULL
recognize	NULL
78-92-kD	NULL
and	NULL
96-100-kD	NULL
proteins	NULL
of	NULL
nuclear	NULL
bodies	NULL
.	NULL

Clin	NULL
Exp	NULL
Immunol	NULL
83:291	NULL
,	NULL
1991	NULL
29	NULL
.	NULL

Korioth	NULL
F	NULL
,	NULL
Gieffers	NULL
C	NULL
,	NULL
Maul	NULL
GG	NULL
,	NULL
Frey	NULL
J	NULL
:	NULL
Molecular	NULL
characterization	NULL
of	NULL
NDP32	NULL
,	NULL
a	NULL
novel	NULL
protein	NULL
of	NULL
the	NULL
nuclear	NULL
domain	NULL
10	NULL
,	NULL
which	NULL
is	NULL
redistributed	NULL
upon	NULL
virus	NULL
infection	NULL
and	NULL
interferon	NULL
treatment	NULL
.	NULL

J	NULL
Cell	NULL
Biol	NULL
130	NULL
:	NULL
1	NULL
,	NULL
1995	NULL
30	NULL
.	NULL

Behrens	NULL
TW	NULL
,	NULL
Jagadeesh	NULL
J	NULL
,	NULL
Scherle	NULL
P	NULL
,	NULL
Kearns	NULL
G	NULL
,	NULL
Yewdell	NULL
J	NULL
,	NULL
Staudt	NULL
LM	NULL
:	NULL
JAW1	NULL
,	NULL
a	NULL
lymphoid-restricted	NULL
membrane	NULL
protein	NULL
localized	NULL
to	NULL
the	NULL
endoplasmic	NULL
reticulum	NULL
.	NULL

J	NULL
Immunol	NULL
153:682	NULL
,	NULL
1994	NULL
31	NULL
.	NULL

Scherle	NULL
P	NULL
,	NULL
Behrens	NULL
T	NULL
,	NULL
Staudt	NULL
LM	NULL
:	NULL
Ly-GDI	NULL
,	NULL
a	NULL
GDP-dissocia-tion	NULL
inhibitor	NULL
of	NULL
the	NULL
RhoA	NULL
GTP-binding	NULL
protein	NULL
,	NULL
is	NULL
expressed	NULL
preferentially	NULL
in	NULL
lymphocytes	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
90:7568	NULL
,	NULL
1993	NULL
32	NULL
.	NULL

Staudt	NULL
LM	NULL
,	NULL
Dent	NULL
A	NULL
,	NULL
Ma	NULL
C	NULL
,	NULL
Allman	NULL
D	NULL
,	NULL
Powell	NULL
J	NULL
,	NULL
Maile	NULL
R	NULL
,	NULL
Scherle	NULL
P	NULL
,	NULL
Behrens	NULL
T	NULL
:	NULL
Rapid	NULL
identification	NULL
of	NULL
novel	NULL
human	NULL
lymphoid-restricted	NULL
genes	NULL
by	NULL
automated	NULL
DNA	NULL
sequencing	NULL
of	NULL
subtracted	NULL
cDNA	NULL
libraries	NULL
.	NULL

Curr	NULL
Top	NULL
Microbiol	NULL
Immunol	NULL
194	NULL
;	NULL
:155	NULL
,	NULL
1994	NULL
33	NULL
.	NULL

Sambrook	NULL
J	NULL
,	NULL
Fritsch	NULL
EF	NULL
,	NULL
Maniatis	NULL
T	NULL
:	NULL
Molecular	NULL
cloning	NULL
:	NULL
A	NULL
Laboratory	NULL
Manual	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
NY	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
,	NULL
1989	NULL
34	NULL
.	NULL

Xie	NULL
K	NULL
,	NULL
Lambie	NULL
E	NULL
,	NULL
Snyder	NULL
M	NULL
:	NULL
Nuclear	NULL
dot	NULL
antigens	NULL
may	NULL
specify	NULL
transcriptional	NULL
domains	NULL
in	NULL
the	NULL
nucleus	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
13:6170	NULL
,	NULL
1993	NULL
35	NULL
.	NULL

Smith	NULL
DB	NULL
,	NULL
Johnson	NULL
KS	NULL
:	NULL
Single-step	NULL
purification	NULL
of	NULL
polypep-tides	NULL
expressed	NULL
in	NULL
Escherichia	NULL
coli	NULL
as	NULL
fusions	NULL
with	NULL
glutathione-S-transferase	NULL
.	NULL

Gene	NULL
67:67	NULL
,	NULL
1988	NULL
36	NULL
.	NULL

Dutilleul	NULL
F	NULL
,	NULL
Venturini	NULL
L	NULL
,	NULL
Guillemin	NULL
MC	NULL
,	NULL
de	NULL
Thé	NULL
H	NULL
,	NULL
Puvion	NULL
E	NULL
:	NULL
Sequestration	NULL
of	NULL
PML	NULL
and	NULL
SP100	NULL
proteins	NULL
in	NULL
an	NULL
intranuclear	NULL
viral	NULL
structure	NULL
during	NULL
herpes	NULL
virus	NULL
simplex	NULL
type	NULL
1	NULL
infection	NULL
.	NULL

Exp	NULL
Cell	NULL
Res	NULL
221:448	NULL
,	NULL
1995	NULL
37	NULL
.	NULL

Tanaka	NULL
M	NULL
,	NULL
Herr	NULL
W	NULL
:	NULL
Differential	NULL
transcriptional	NULL
activation	NULL
by	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
:	NULL
Interdependent	NULL
activation	NULL
domains	NULL
induce	NULL
Oct-2	NULL
phosphorylation	NULL
.	NULL

Cell	NULL
60:375	NULL
,	NULL
1990	NULL
38	NULL
.	NULL

Roth	NULL
J	NULL
:	NULL
Post-embedding	NULL
labeling	NULL
on	NULL
Lowicryl	NULL
K4M	NULL
tissue	NULL
sections	NULL
:	NULL
Detection	NULL
and	NULL
modification	NULL
of	NULL
cellular	NULL
components	NULL
,	NULL
in	NULL
Tar-tikoff	NULL
AM	NULL
(	NULL
ed	NULL
)	NULL
:	NULL
Methods	NULL
in	NULL
Cell	NULL
Biology	NULL
.	NULL

New	NULL
York	NULL
,	NULL
NY	NULL
,	NULL
Academic	NULL
,	NULL
1989	NULL
,	NULL
p	NULL
513	NULL
39	NULL
.	NULL

Kadereit	NULL
S	NULL
,	NULL
Gewert	NULL
DR	NULL
,	NULL
Galabru	NULL
J	NULL
,	NULL
Hovanessian	NULL
AG	NULL
,	NULL
Meurs	NULL
EF	NULL
:	NULL
Molecular	NULL
cloning	NULL
of	NULL
two	NULL
new	NULL
interferon-induced	NULL
,	NULL
highly	NULL
related	NULL
nuclear	NULL
phosphoproteins	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
268:24432	NULL
,	NULL
1993	NULL
40	NULL
.	NULL

Koken	NULL
MHM	NULL
,	NULL
Saib	NULL
A	NULL
,	NULL
de	NULL
Thé	NULL
H	NULL
:	NULL
A	NULL
C4HC3	NULL
zinc	NULL
finger	NULL
motif	NULL
.	NULL

C	NULL
R	NULL
Acad	NULL
Sci	NULL
318:733	NULL
,	NULL
1995	NULL
41	NULL
.	NULL

Aasland	NULL
R	NULL
,	NULL
Gibson	NULL
TJ	NULL
,	NULL
Stewart	NULL
AF	NULL
:	NULL
The	NULL
PHD	NULL
finger	NULL
:	NULL
Implica-	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1436	NULL
tions	NULL
for	NULL
chromatin	NULL
mediated	NULL
transcriptional	NULL
regulation	NULL
.	NULL

Trends	NULL
Biochem	NULL
Sci	NULL
20:56-59	NULL
,	NULL
1995	NULL
42	NULL
.	NULL

Haynes	NULL
SR	NULL
,	NULL
Dollard	NULL
C	NULL
,	NULL
Winston	NULL
F	NULL
,	NULL
Beck	NULL
S	NULL
,	NULL
Trowsdale	NULL
J	NULL
,	NULL
Dawid	NULL
IB	NULL
:	NULL
The	NULL
bromodomain	NULL
:	NULL
A	NULL
conserved	NULL
sequence	NULL
found	NULL
in	NULL
hu-man	NULL
,	NULL
Drosophila	NULL
and	NULL
yeast	NULL
proteins	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
20:2603	NULL
,	NULL
1992	NULL
43	NULL
.	NULL

Le	NULL
Douarin	NULL
B	NULL
,	NULL
Zechel	NULL
C	NULL
,	NULL
Garnier	NULL
J-M	NULL
,	NULL
Lutz	NULL
Y.	NULL
Tora	NULL
L	NULL
,	NULL
Pierrat	NULL
B	NULL
,	NULL
Heery	NULL
D	NULL
,	NULL
Gronemeyer	NULL
H	NULL
,	NULL
Chambon	NULL
P	NULL
,	NULL
Losson	NULL
R	NULL
:	NULL
The	NULL
N-terminal	NULL
part	NULL
of	NULL
TIF1	NULL
,	NULL
a	NULL
putative	NULL
mediator	NULL
of	NULL
the	NULL
ligand-dependent	NULL
activation	NULL
function	NULL
(	NULL
AF-2	NULL
)	NULL
of	NULL
nuclear	NULL
receptors	NULL
,	NULL
is	NULL
fused	NULL
to	NULL
B-raf	NULL
in	NULL
the	NULL
oncogenic	NULL
protein	NULL
T8	NULL
.	NULL

EMBO	NULL
J	NULL
14:2020	NULL
,	NULL
1995	NULL
44	NULL
.	NULL

Chrivia	NULL
JC	NULL
,	NULL
Kwok	NULL
RPS	NULL
,	NULL
Lamb	NULL
N	NULL
,	NULL
Hagiwara	NULL
M	NULL
,	NULL
Montminy	NULL
MR	NULL
,	NULL
Goodman	NULL
RH	NULL
:	NULL
Phosphorylated	NULL
CREB	NULL
binds	NULL
specifically	NULL
to	NULL
the	NULL
nuclear	NULL
protein	NULL
CBP	NULL
.	NULL

Nature	NULL
365:855	NULL
,	NULL
1993	NULL
45	NULL
.	NULL

Eckner	NULL
R	NULL
,	NULL
Ewen	NULL
ME	NULL
,	NULL
Newsome	NULL
D	NULL
,	NULL
Gerdes	NULL
M	NULL
,	NULL
DeCaprio	NULL
JA	NULL
,	NULL
Lawrence	NULL
JB	NULL
,	NULL
Livingston	NULL
DM	NULL
:	NULL
Molecular	NULL
cloning	NULL
and	NULL
functional	NULL
analysis	NULL
of	NULL
the	NULL
adenovirus	NULL
ElA-associated	NULL
300-kD	NULL
protein	NULL
(	NULL
p300	NULL
)	NULL
reveals	NULL
a	NULL
protein	NULL
with	NULL
properties	NULL
of	NULL
a	NULL
transcriptional	NULL
adaptor	NULL
.	NULL

Genes	NULL
Dev	NULL
8:869	NULL
,	NULL
1994	NULL
46	NULL
.	NULL

Fu	NULL
XD	NULL
,	NULL
Maniatis	NULL
T	NULL
:	NULL
Factor	NULL
required	NULL
for	NULL
mammalian	NULL
spliceo-some	NULL
assembly	NULL
is	NULL
localized	NULL
to	NULL
discrete	NULL
regions	NULL
in	NULL
the	NULL
nucleus	NULL
.	NULL

Nature	NULL
343:437	NULL
,	NULL
1990	NULL
47	NULL
.	NULL

Andrade	NULL
LE	NULL
,	NULL
Chan	NULL
EK	NULL
,	NULL
Raska	NULL
I	NULL
,	NULL
Peebles	NULL
CL	NULL
,	NULL
Roos	NULL
G	NULL
,	NULL
Tan	NULL
EM	NULL
:	NULL
Human	NULL
autoantibody	NULL
to	NULL
a	NULL
novel	NULL
protein	NULL
of	NULL
the	NULL
nuclear	NULL
coiled	NULL
body	NULL
:	NULL
Immunological	NULL
characterization	NULL
and	NULL
cDNA	NULL
cloning	NULL
of	NULL
p8O-coilin	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
173:1407	NULL
,	NULL
1991	NULL
48	NULL
.	NULL

Lavau	NULL
C	NULL
,	NULL
Marchio	NULL
A	NULL
,	NULL
Fagioli	NULL
M	NULL
,	NULL
Jansen	NULL
J	NULL
,	NULL
Falini	NULL
B	NULL
,	NULL
Lebon	NULL
P	NULL
,	NULL
Grosveld	NULL
F.	NULL
Pandolfi	NULL
P	NULL
,	NULL
Pelicci	NULL
P	NULL
,	NULL
Dejean	NULL
A	NULL
:	NULL
The	NULL
acute	NULL
promyelocytic	NULL
leukaemia-associated	NULL
PML	NULL
gene	NULL
is	NULL
induced	NULL
by	NULL
interferon	NULL
.	NULL

Oncogene	NULL
11:871	NULL
,	NULL
1995	NULL
49	NULL
.	NULL

Guldner	NULL
HH	NULL
,	NULL
Szostecki	NULL
C	NULL
,	NULL
Grotzinger	NULL
T	NULL
,	NULL
Will	NULL
H	NULL
:	NULL
IFN	NULL
enhances	NULL
expression	NULL
of	NULL
sp100	NULL
,	NULL
an	NULL
autoantigen	NULL
in	NULL
primary	NULL
biliary	NULL
cirmho-sis	NULL
.	NULL

J	NULL
Immunol	NULL
149:4067	NULL
,	NULL
1992	NULL
50	NULL
.	NULL

Mazo	NULL
AM	NULL
,	NULL
Huang	NULL
DH	NULL
,	NULL
Mozer	NULL
BA	NULL
,	NULL
Dawid	NULL
IB	NULL
:	NULL
The	NULL
trithorax	NULL
DENT	NULL
ET	NULL
AL	NULL
gene	NULL
,	NULL
a	NULL
trans-acting	NULL
regulator	NULL
of	NULL
the	NULL
bithorax	NULL
complex	NULL
in	NULL
Drosophila	NULL
,	NULL
encodes	NULL
a	NULL
protein	NULL
with	NULL
zinc-binding	NULL
domains	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
87:2112	NULL
,	NULL
1990	NULL
51	NULL
.	NULL

Arany	NULL
Z	NULL
,	NULL
Newsome	NULL
D	NULL
,	NULL
Oldread	NULL
E	NULL
,	NULL
Livingston	NULL
DM	NULL
,	NULL
Eckner	NULL
R	NULL
:	NULL
A	NULL
family	NULL
of	NULL
transcriptional	NULL
adaptor	NULL
proteins	NULL
targeted	NULL
by	NULL
the	NULL
ElA	NULL
oncoprotein	NULL
.	NULL

Nature	NULL
374:81	NULL
,	NULL
1995	NULL
52	NULL
.	NULL

Lundblad	NULL
JR	NULL
,	NULL
Kwok	NULL
RP	NULL
,	NULL
Laurance	NULL
ME	NULL
,	NULL
Harter	NULL
ML	NULL
,	NULL
Goodman	NULL
RH	NULL
:	NULL
Adenoviral	NULL
E1	NULL
A-associated	NULL
protein	NULL
p300	NULL
as	NULL
a	NULL
functional	NULL
homologue	NULL
of	NULL
the	NULL
transcriptional	NULL
co-activator	NULL
CBP	NULL
.	NULL

Nature	NULL
374:85	NULL
,	NULL
1995	NULL
53	NULL
.	NULL

Gu	NULL
Y	NULL
,	NULL
Nakamura	NULL
T	NULL
,	NULL
Alder	NULL
H	NULL
,	NULL
Prasad	NULL
R	NULL
,	NULL
Canaani	NULL
O0	NULL
,	NULL
Cimino	NULL
G	NULL
,	NULL
Croce	NULL
CM	NULL
,	NULL
Canaani	NULL
E	NULL
:	NULL
The	NULL
t	NULL
(	NULL
4	NULL
;	NULL
11	NULL
)	NULL
chromosome	NULL
translocation	NULL
of	NULL
human	NULL
acute	NULL
leukemias	NULL
fuses	NULL
the	NULL
ALL-1	NULL
gene	NULL
,	NULL
related	NULL
to	NULL
Drosophila	NULL
trithorax	NULL
,	NULL
to	NULL
the	NULL
AF-4	NULL
gene	NULL
.	NULL

Cell	NULL
71:701	NULL
,	NULL
1992	NULL
54	NULL
.	NULL

Tkachuk	NULL
DC	NULL
,	NULL
Kohler	NULL
S	NULL
,	NULL
Cleary	NULL
ML	NULL
:	NULL
Involvement	NULL
of	NULL
a	NULL
homo-log	NULL
of	NULL
Drosophila	NULL
trithorax	NULL
by	NULL
11q23	NULL
chromosomal	NULL
translocations	NULL
in	NULL
acute	NULL
leukemias	NULL
.	NULL

Cell	NULL
71:691	NULL
,	NULL
1992	NULL
55	NULL
.	NULL

Ruppert	NULL
S	NULL
,	NULL
Wang	NULL
EH	NULL
,	NULL
Tjian	NULL
R	NULL
:	NULL
Cloning	NULL
and	NULL
expression	NULL
of	NULL
human	NULL
TAFH250	NULL
:	NULL
;	NULL
A	NULL
TBP-associated	NULL
factor	NULL
implicated	NULL
in	NULL
cell-cycle	NULL
regulation	NULL
.	NULL

Nature	NULL
362:175	NULL
,	NULL
1993	NULL
56	NULL
.	NULL

Hisatake	NULL
K	NULL
,	NULL
Hasegawa	NULL
S	NULL
,	NULL
Takeda	NULL
R	NULL
,	NULL
Nakatani	NULL
Y	NULL
,	NULL
Horikoshi	NULL
M	NULL
,	NULL
Roeder	NULL
RG	NULL
:	NULL
The	NULL
p250	NULL
subunit	NULL
of	NULL
native	NULL
TATA	NULL
box-binding	NULL
factor	NULL
TFIID	NULL
is	NULL
the	NULL
cell-cycle	NULL
regulatory	NULL
protein	NULL
CCG1	NULL
.	NULL

Nature	NULL
362:179	NULL
,	NULL
1993	NULL
57	NULL
.	NULL

Wang	NULL
EH	NULL
,	NULL
Tjian	NULL
R	NULL
:	NULL
;	NULL
Promoter-selective	NULL
transcriptional	NULL
defect	NULL
in	NULL
cell	NULL
cycle	NULL
mutant	NULL
ts13	NULL
rescued	NULL
by	NULL
hTAFII250	NULL
.	NULL

Science	NULL
263:811	NULL
.	NULL

1994	NULL
58	NULL
.	NULL

Peterson	NULL
CL	NULL
:	NULL
The	NULL
SWI-SNF	NULL
complex	NULL
:	NULL
A	NULL
chromatin	NULL
remodeling	NULL
machine	NULL
?	NULL

Trends	NULL
Biochem	NULL
Sci	NULL
20:143	NULL
,	NULL
1995	NULL
59	NULL
.	NULL

Marcus	NULL
GA	NULL
,	NULL
Silverman	NULL
N	NULL
,	NULL
Berger	NULL
SL	NULL
,	NULL
Horiuchi	NULL
J	NULL
,	NULL
Guarente	NULL
L	NULL
:	NULL
Functional	NULL
similarity	NULL
and	NULL
physical	NULL
association	NULL
between	NULL
GCN3S	NULL
and	NULL
ADA2	NULL
:	NULL
Putative	NULL
transcriptional	NULL
adaptors	NULL
.	NULL

EMBO	NULL
J	NULL
13:4807	NULL
,	NULL
1994	NULL
60	NULL
.	NULL

Mattaj	NULL
IW	NULL
,	NULL
Boelens	NULL
W.	NULL
Izaurralde	NULL
E	NULL
,	NULL
Jarmolowski	NULL
A	NULL
,	NULL
Kam-bach	NULL
C	NULL
:	NULL
Nucleocytoplasmic	NULL
transport	NULL
and	NULL
snRNP	NULL
assembly	NULL
.	NULL

Mol	NULL
Biol	NULL
Rep	NULL
18:79	NULL
,	NULL
1993	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

®	NULL
blO	NULL
0d	NULL
1996	NULL
88	NULL
:	NULL
1423-1426	NULL
LYSP100-associated	NULL
nuclear	NULL
domains	NULL
(	NULL
LANDs	NULL
)	NULL
:	NULL
description	NULL
of	NULL
a	NULL
new	NULL
class	NULL
of	NULL
subnuclear	NULL
structures	NULL
and	NULL
their	NULL
relationship	NULL
to	NULL
PML	NULL
nuclear	NULL
bodies	NULL
TY	NULL
O	NULL
0C	NULL
,	NULL
A	NULL
f	NULL
gm	NULL
“	NULL
CA	NULL
N	NULL
,	NULL
6	NULL
'	NULL
%	NULL
:	NULL
r	NULL
)	NULL
...	NULL
3\	NULL
2	NULL
``	NULL
O10	NULL
(	NULL
@	NULL
0	NULL
AL	NULL
Dent	NULL
,	NULL
J	NULL
Yewdell	NULL
,	NULL
F	NULL
Puvion-Dutilleul	NULL
,	NULL
MH	NULL
Koken	NULL
,	NULL
H	NULL
de	NULL
The	NULL
and	NULL
LM	NULL
Staudt	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/88/4/1423.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

